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Context    Among other things, the American Recovery and Reinvestment Act of 2009 
(ARRA) provided financial incentives for certain medical providers to adopt and meaningfully 
use certified Electronic Health Records (EHR).  Health Information Technology (HIT), 
particularly EHRs, may improve the quality of health care.  
Objective    To estimate the effect of Electronic Health Records (EHR) implemented by 
Maryland Medicaid managed care network physicians participating in the Maryland EHR 
Incentive Program on a Healthcare Effectiveness Data and Information Set (HEDIS®)-like 
measure for immunization administration. 
Design, Setting, and Participants    This study used an interrupted time series to 
estimate the impact of EHR use on the quality of care provided to Maryland Medicaid managed 
care recipients.  Data are analyzed using a hierarchical model. The time period for this study is 
2010 through 2014, with the intervention period, calendar year 2013. To be included in the 
intervention group, a physician must have met HEDIS®-like inclusion criteria and measurement 
thresholds for Childhood Immunization Status (NQF 0038, Combination 7) and must have met 
“Meaningful Use” during calendar year 2013 (147 providers); matched comparisons came from 
Maryland Medicaid Managed Care Organization (MCO) network providers. 
Main Outcome Measure    The estimated effect of EHR use on HEDIS®-based quality 
metric, Childhood Immunization Status (CIS) Combination 7, comparing EHR users to non-
users pre-and post-implementation of the EHR Incentive Program in Maryland Medicaid. 
Results and Implications   Based on prior information and the probabilities calculated 
with this data set for Maryland Medicaid MCO network providers, in the two-year post-EHR 





meeting CIS Combination 7, comparing providers meeting Meaningful Use with Clinical Quality 
Measure (eCQM) National Quality Forum 0038 “Childhood Immunization Status,” to non-EHR 
users. 
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As a percent of Gross Domestic Product (GDP) and per capita, the United States spends 
more on health care than any other industrialized nation; yet, the quality of care received is 
variable (Squires, 2012). Historically, the United States’ growth rate in GDP and per capita 
health care spending has far outpaced other nations, driven in part by health care technology 
(Squires 2012, Feldstein, 2007).  
Despite the potential correlation between increased health care costs and technology, in 
2009 the United States embarked on a major health information technology (HIT) expansion. 
This expansion arose primarily from research highlighting some of the benefits of HIT.  HIT 
may reduce costs and inefficiencies in health care by electronically linking doctors, insurance 
providers, pharmacies, and government institutions to consumers and their individual health 
information. Cost savings may be achieved through reduction in administrative overhead, while 
inefficiencies mitigated through better monitoring of health care services, particularly duplicative 
treatments and tests. The quality of health care could be improved by providing on-demand 
integrated and longitudinal patient information, guideline-based care, and decision support (Zhou 
et al., 2009). Total cost savings due to HIT could reach $80 billion (Girosi, Federico, Meili, 





To encourage EHR adoption, the U.S. government invested an estimated $37 billion 
dollars in incentive payments to providers participating in the Electronic Health Records 
Incentive Program (Active Registrations: December 2017 EHR Incentive Program, 2017). The 
total investment in the EHR Incentive Program is likely more than $37 billion due to state 
administrative costs.  The EHR Incentive Program provides financial incentives for certain 
providers and hospitals to adopt and then “meaningfully use” federally-certified EHRs (Thune, 
John, Alexander, Lamar, Roberts, Pat, Burr, Richard, Coburn, Thomas, Enzi, 2013).  
Due in part to the only-recently widespread use of certified EHRs and the difficulty in 
isolating the impact of EHR use and particular EHR functionality on outcomes, few studies exist 
to explore the relationship between EHR use and the quality of health care. Absent this 
information, it is unclear whether EHRs do or will deliver on any of its potential benefits. If 
EHRs are able to improve the quality of health care, the use of EHRs by Medicaid providers 
could improve the quality of health care delivered to one of the core recipients of Medicaid 




The primary aim of this study is to estimate the effect on health care quality of Electronic 
Health Records (EHR) implemented by certain Maryland Medicaid managed care network 
providers. This study compares a modified, process-based quality metric specified by the Agency 
for Healthcare Research and Quality’s (AHRQ) Healthcare Effectiveness Data Information Set 
(HEDIS®) that aligns closely with the quality measure specified in the EHR Incentive Program. 
The HEDIS® quality metric is the Childhood Immunization Status (CIS) measured as the 





HEDIS® specifies up to ten combinations of vaccinations with the following frequencies: 
The percent of children who by their second birthday had four diphtheria, tetanus and acellular 
pertussis (DTaP); three polio (IPV); one measles, mumps and rubella (MMR); two H influenza 
type B (HiB); three hepatitis B (HepB), one chicken pox (VZV); four pneumococcal conjugate 
(PCV); two hepatitis A (HepA); two or three rotavirus (RV); and two influenza (flu) vaccines. 
Although influenza is included in the HEDIS® CIS measure, I excluded this vaccination in this 
analysis because its delivery is seasonal. Additionally, I considered a Medicaid recipient up-to-
date with their HepB vaccination if they received at least two of three required doses because this 
study focuses on physicians who act as a Medicaid recipient’s Primary Care Provider (PCP), and 
the HepB vaccine can be administered at birth.  
Additional aims of this study include: 
 Investigating whether quality differs by EHR developer, and 
 Discussing the implications of EHR use on physician quality reporting and pay-
for-outcomes policies. 
Maryland launched the Medicaid EHR Incentive Program in 2011, making its first 
incentive payment in December of that year. The EHR Incentive Program pays providers a 
financial incentive for first adopting and then in later years “meaningfully using” their EHR. 
During the timeframe of this study, the Centers for Medicare and Medicaid Services (CMS) 
defined “meaningful use” through rulemaking via a list of “core” and “menu set” objectives and 
electronic Clinical Quality Measures (eCQM). Recent rulemaking has abolished the “core” and 
“menu” set paradigm, but has preserved eCQMs, including the immunization measure used in 





achieve “meaningful use” have optimized their EHRs, increasing the probability of improved 
quality and reduced cost. 
Currently, Maryland evaluates the quality of health care delivered by Managed Care 
Organizations (MCOs) using HEDIS®. HEDIS® contains a series of standardized process-based 
quality measures from which Maryland Medicaid chooses select items to compare MCOs and to 




As health care practitioners move from adopting EHRs to implementing them into their 
workflow, it is important to assess whether their acquisition is reducing cost and improving 
quality, and, if so, in what situations. 
Between 2009 and 2013, the Federal government paid out almost $7 billion dollars in 
incentives to over 147,000 providers (Centers for Medicare and Medicaid Services, 2014b). In 
2011, across all health care providers in the United States, an estimated 54 percent had adopted 
an EHR (E. Jamoom et al., 2012).  
In 2010, an estimated 23.7 percent of providers nationally had adopted an EHR, which 
mirrored the adoption rate among the Maryland Medicaid provider population (Maryland 
Department of Health and Mental Hygiene, 2014). In 2013, the estimated EHR adoption rate 
among the Medicaid provider population had grown to nearly 50 percent (Maryland Department 
of Health and Mental Hygiene, 2014). By 2017, the Maryland Department of Health estimated 
adoption rate among Medicaid provider population to be 74 percent (Maryland Department of 
Health, 2017). Between 2011 and 2014, Maryland paid over 2,278 providers a total of more than 





As enrollment in the EHR Incentive Program continues to grow, Medicaid agencies will 
have new options for measuring quality, such as using quality data to better understand the 
relationship between an individual provider or their care team’s contribution to patient outcomes. 
Before the EHR Incentive Program, the relatively low use of EHRs and the non-standard nature 
of EHR products made calculating and tracking outcomes across providers difficult. Within 
Medicaid agencies, HEDIS® is the primary method of tracking quality. HEDIS® generally uses 
administrative data with occasionally hybrid methodologies for medical record data supplements 
to calculate their process-based quality measures.  
HEDIS® managed care measures pool data across managed care plans and do not assess 
individual providers. With standardized EHR systems, Medicaid agencies will soon be able to 
collect patient-level data by provider to compare like providers to like providers longitudinally, 
allowing for pay-for-outcomes models. However, until the adoption of certified EHRs is 
widespread, any longitudinal analysis of quality must rely on HEDIS®-like quality 
methodologies.  
Some process-based measures have an outcome focus; for example, immunization status 
is linked to reductions in mortality. Using a systematic review and analysis of national data and 
applying it to a hypothetical birth cohort of 4 million US-Census based individuals, Maciosek et 
al., (2006), estimated that administering vaccinations in accordance with national childhood 
immunization schedules is a highly cost-effective intervention that could result in saving greater 
than 360,000 quality-adjusted life years (QALY) (2006). Although vaccination schedules vary 
worldwide and few studies exist that measure the association between immunization schedules, 
health outcomes, and adverse events, vaccines have contributed significantly to reductions in 





Despite the importance of vaccination for reducing morbidity and mortality, the 
immunization rate in the United States remains below national targets. In 2013, 70.4 percent of 
children ages 19-35 months received the full Center for Disease Control and Prevention (CDC) 
recommended vaccine series (Elam-Evans, Laurie D, Yankey, David, Singleton, James A., 
Kolasa, 2014). For Medicaid children up through age 2 in 2014, the national mean immunization 
rate was 62.1 percent (Burwell, 2016).1 
  
                                                 
1 The immunization rate is reported using Combination 3, which includes vaccination administration for DTAP, 










DEFINING HEALTH CARE QUALITY 
 
Historically, approaches to measuring the quality of health care followed Donabedian’s 
structure, process, and outcomes framework (1966). “Structure” includes the conditions under 
which care is provided; “process” includes how care is delivered; and “outcomes” are the results 
of care (Donabedian, 1966). According to Rubin, Provonost, and Diette, process measures are 
appealing quality assessment tools because they can be actionable, avoid the need for patient-
level risk adjustment, and have the potential to link to outcomes (Rubin, Pronovost, & Diette, 
2001).  Since they are ultimately the result of a health-care intervention, outcomes-based 
measures may be more preferable to process-based measures; however, the complexity and 
expense of developing and standardizing these measures has reduced their widespread use 
(Rubin et al., 2001).  
 Identifying quality measures for the U.S. health care market using Donabedian’s 
framework is difficult. Part of the difficulty in identifying quality measures is that each of the 
various stakeholders who participate in the traditional U.S. health care system has a unique 
perspective on health care. Figure 1 provides a simplified diagram for viewing the interactions 
among the three major health care stakeholders (providers, payors, and patients), taking into 
account their basic functions, interests and motivations in the health care market, and 





Achieving convergence on an approach to measuring quality requires balancing these competing 




































Basic Functions: Administer health-related 
services to patients and interact with 
payers to receive reimbursement for 
services rendered. 
Interests:  Provide health care that 
maximizes income from patients and 
payers, minimizes costs associated with 
delivery, and improve patient health status. 
Perspective on Quality: Traditionally, 
providers focus on technical expertise that 
leads to health status improvement, with 
the cost of care a secondary concern. 
Increasingly, providers view quality as 
including patient satisfaction, outcomes, 
and cost-effectiveness.  
 
Patients 
Basic Functions: Schedule and visit 
providers for services and obtain health 
insurance from payers or pay out-of-
pocket for services administered by 
providers. 
Interests: Use available resources to 
obtain the highest level of care for the 
least realized cost.  
Perspective on Quality: Without health 
quality measures or medical 
knowledge, patients tend to evaluate 
care based on responsiveness to needs, 
including alleviation of problems, 




Basic Functions: Enter into agreements between patients and providers to: (1) obtain payments 
from patients for services rendered by providers, and (2) reimburse providers for services 
rendered to patients. 
Interests: Provide cost-effective and necessary care to patients while reducing expenditures to 
providers. 
Perspective on Quality: Minimizing costs by avoiding costly plan purchasers and applying cost-
effective and appropriate care. 
* The term “payors” refers to any entity paying some or all of a provider’s bill on behalf of the patient. 






Preventative services are a good example of where provider, patient, and payer 
expectations for quality may intersect. Preventative services, such as childhood vaccinations, 
meet the quality expectations of patients and payers in that they are both effective at reducing 
mortality and morbidity and cost-effective (Maciosek et al., 2006). In addition to their 
effectiveness in reducing mortality and morbidity, childhood vaccinations may also appeal to 
provider expectations of quality in that they are easy to administer and require relatively minimal 
effort to achieve compliance, particularly with the aid of IT systems (McGlynn, 1997). 
Further, childhood vaccines are often available for free through the federal Vaccines for 
Children (VFC) program, and, among the Maryland Medicaid population, vaccine administration 
is reimbursed at the same rate, regardless of the vaccine. These financial factors may make it 
more likely that if a provider provides any childhood vaccines to Medicaid recipients, the 
provider may provide them all. 
 Even though childhood vaccinations may provide a good service for defining health care 
quality, determining how to measure the administration of childhood vaccinations is challenging. 
Based on such factors as the type of vaccine, recipient age, and recipient’s immune status, the 
timing and dose of the vaccine matters (Kroger, Sumaya, Pickering, & Atkinson, 2011). These 
factors combine to determine the optimal effectiveness of the vaccine to elicit a protective 
immunoresponse. To help ensure the timely administration of the appropriate dosage of vaccines 
to be administered to persons aged 0-18 years, the Advisory Committee for Immunization 
Practices for the CDC annually publishes a recommended vaccine schedule.2  
Despite the importance of the timing and dose of the vaccine, timeliness and over-
immunization (excessive dose) are not fully factored into traditional process-based 
                                                 





measurements of immunization quality. The National Committee for Quality Assurance (NCAQ) 
relies on process-based measures to develop their HEDIS® program. Over 90 percent of health 
care plans, particularly Medicaid Managed Care plans, use HEDIS® scoring to measure quality 
(Bundy, Solomon, Kim, & Miller, 2012). One of the HEDIS® measures is childhood 
immunization status score. HEDIS® measures immunization status by looking at the number of 
children by age 2 that receive the recommended doses of vaccines as administered by the health 
care plan’s network providers.  
Glauber (2003) notes that NCAQ’s approach to measuring immunization status does not 
adequately address childhood immunization statuses because: 
1. By combining all immunizations that should be delivered by age 2, HEDIS® will 
consider a child not up-to-date whether they miss one or all recommended 
immunizations. 
2. The determination of the status of “up-to-date” depends on obtaining all 
recommended doses of any one vaccine, even if obtaining later doses are the least 
biologically relevant doses.  
3. Measuring up-to-date status based at age 2 fails to take into account the timeliness 
of each vaccination. 
Further, HEDIS® only looks at within-health-plan immunization administration. It does not take 
into account whether a recipient received an immunization from an out-of-network provider. The 
implications of not factoring in out-of-network vaccination administration may lead to extra-
immunization, which is an inefficient use of resources and potentially harmful to patients 
(Feikema, 2000). The differential impact of Medicaid insurance status compared to commercial 





Thus, quality analysis of immunization status may need to rely on the HEDIS®-based 
approach to provide for benchmarking but should not solely rely on HEDIS®. Instead, quality 
reporting of immunization status should supplement HEDIS® by making a clinically relevant 
measurement of timeliness and leverage data from vaccine registries or other health care system 
wide data to reduce extra-immunization. 
 
THEORETICAL BASIS FOR QUALITY IMPROVEMENT 
 
 Generally, EHR systems show evidence of quality improvement when it comes to aiding 
in protocol or guideline-based care (Chaundhry et al., 2006). Using EHRs to guide care may 
prevent costly medical errors, such as adverse drug events, or unnecessary health services. Some 
studies cite the potential reduction in medical errors from HIT between 50 and over 90 percent 
(Congressional Budget Office, 2008). A 2014 systematic review of 28 randomized control trials 
implementing rule- or algorithm-based Clinical Decision Support (CDS) integrated with an EHR 
found marginal positive impacts on morbidity and no effect on mortality (Moja et al., 2014). And 
while the use of HIT, particularly CDS, may reduce medical errors and provide guidance on 
protocol, research does not support the assumption that improved care necessarily improves 
patients’ health or reduces costs (Congressional Budget Office, 2008). As applied to vaccine-
based interventions, CDS impacts on vaccination rates varies (Sittig, Teich, Osheroff, & Singh, 
2009; Stockwell & Fiks, 2013). 
However, before the creation of the EHR Incentive Program in 2009, few hospitals and 
health care providers had adopted an EHR, and those that did adopt these systems customized 
them to meet particular health-care needs (Congressional Budget Office, 2008). Using a national 





et al., 2006). A 2007 survey by the American Hospital Association estimated EHR an 11 percent 
EHR adoption rate by non-federal hospitals (Congressional Budget Office, 2008).  Because of 
the proliferation of customized EHRs, nearly any evidence correlating the use of EHRs with 
quality improvement could not easily be generalized. To better standardize and ensure the 
availability of quality-impacting EHR functionality and to guarantee that health care providers or 
hospitals participating in the Medicare or Medicaid EHR Incentive Programs have access to the 
technology necessary to meet Incentive Program requirements, the federal government created 
national standards and certification requirements for EHRs. By creating a national EHR 
certification program, the federal government increased the probability that providers adopting 
EHRs would implement those EHR functionalities with the strongest link to improving health 
care quality.  
 
 
CERTIFIED ELECTRONIC HEALTH RECORD TECHNOLOGY (CEHRT) 
 
 Periodically, the Department of Health and Human Services’ Office of the National 
Coordinator (ONC) promulgates rules for EHRs to receive federal certification. ONC generally 
promulgates Certified Electronic Health Record Technology (CEHRT) rules to coincide with the 
various stages of Meaningful Use.  In anticipation of providers and hospitals preparing for 
Meaningful Use Stage 1, ONC published the requirements for 2011 Edition CEHRT in July of 
2010 (HHS, 2010). For Program Year 2013, all providers and hospitals participating in the 
Medicare or Medicaid EHR Incentive Program must have EHR technology certified to the 2011 
CEHRT edition. Due to flexibility afforded to Medicare and Medicaid Incentive Program 





2011 CEHRT to meet Meaningful Use until Program Year 2015 (U.S. Department of Health & 
Human Services, 2013). 
 In regards to the Meaningful Use Stage 1 public health measure, “capability to submit 
electronic data to immunization registries … and actual submission in accordance with 
applicable laws and practice,” an EHR certified to the 2011 Edition of CEHRT must have been 
able to “electronically record, modify, retrieve, and submit immunization information in 
accordance with” Health Level 7 (HL7) version 2.3.1 and 2.5.1 (HHS, 2010).  
However, obtaining 2011 Edition CEHRT did not guarantee that a health care provider 
could export and transport a message acceptable to any State’s Immunization Information 
System (IIS). In many cases, each State or jurisdiction uses the HL7 Implementation Guide as a 
starting point, adding other nuances or required fields within the message. Additionally, in 
response to a Congressional request to report on the pervasiveness of health information 
blocking, the ONC reported that some EHR vendors charge providers to send, receive, or export 
health information (Office of the National Coordinator, 2015). Since public health reporting 
requires the sending or exporting of health information, it is likely that meeting any public health 
measure may be difficult for some providers with CEHRT. 
Additionally, a health care provider who obtained a 2011 Edition CEHRT would not 
necessarily know whether or not their product could be configured to trigger a Clinical Decision 
Support (CDS) rule for vaccinations. According to 2011 Edition CEHRT requirements, CDS 
must have been available for real-time notifications and care suggestions based on data elements 
from “medication lists; demographics; and laboratory test results” (HHS, 2010). Thus, the 
certification requirement ensures the capability is present within any 2011 Edition CEHRT, but 





present in the EHR product, and the willingness of the EHR purchaser to code and invoke a 
specific CDS. Because 2011 Edition CEHRT stopped short of prescribing the exact types of 
CDS available, there is no way from a CEHRT Identification Number to determine whether a 
particular product offers or if a purchaser of a particular product enables a vaccine-based CDS 
rule. 
In 2011, the CDC convened an expert panel to assist with determining rules around 
Clinical Decision Support for Immunizations (CDSi) (Artz, 2016). As described by Artz, CDSi 
could vary in sophistication, from web-based standard transactions with an IIS or simple 
demographic-based rules to remind health care providers for the need to administer vaccinations 
(2016). 
 
EHR ADOPTION CHALLENGES  
 
Despite the potential gains for EHR adopters, financial, technical, and time barriers may 
hinder the widespread adoption of EHRs. A systematic literature review of health care providers’ 
barriers to EHR adoption by Boonstra and Broekhuis (2010) identified these categories as the 
most frequently cited among the literature. These barriers to EHR adoption are often cited by 
Maryland Medicaid providers as well (Maryland Department of Health and Mental Hygiene, 
2014).  
Financial barriers include high start-up and on-going maintenance and support costs 
(Boonstra & Broekhuis, 2010). Technical barriers include difficulties in selection, integrating, 
and operating a new system (Boonstra & Broekhuis, 2010). Time barriers are related to the 





selecting a system, to training on the system, and finally working on the system instead of 
conversing with patients (Boonstra & Broekhuis, 2010). 
In looking at a 2011 nationally representative sample of non-federal office-based 
providers EHR adopters compared to non-adopters, Jamoom et al. found that, while the cost of 
purchasing remained the number one barrier for EHR adopters (52%) and non-adopters (73%), 
both adopters and non-adopters ranked the perception of productivity loss as the second greatest 
barrier (37% versus 59%, respectively) (E. W. Jamoom, Patel, Furukawa, & King, 2014).  
 
CHALLENGES FOR QUALITY IMPROVEMENT 
 
 Although EHR systems leverage a logical and standardized data structure to record and 
extract clinical data, simply possessing an EHR does not necessarily equate to more reliable and 
valid quality reporting. Further, a nation-wide change from International Classification of 
Disease (ICD) version 9 to ICD-10 coding on October 1, 2015 will likely impact longitudinal 
comparison of guideline-based quality reporting.  
A review of empirical studies conducted by Chan, Fowles, and Weiner concluded that the 
reliability of quality reporting varied by EHR functional modules (e.g., problem and medication 
lists), data documentation and extraction strongly influenced quality outcomes, and the use of 
and extraction process for free-text fields may prove problematic for quality reporting (Chan, 
Fowles, & Weiner, 2010). 
 However, because EHRs can be used to record information as structured data at the point 
of care, the data recorded as clinical data may be more complete and reliable than administrative 
data, the traditional method for quality evaluation. Some quality-based measures calculate the 





as patients with heart disease or diabetes (Rubin et al., 2001). The identification of these disease 
states is generally coded using ICD-9. In these situations, identifying the target population 
(denominator) is critical. When comparing the target population for diabetes care using paper 
medical records abstractions versus EHR data queries, Tang et al. found a 22 percentage point 
increase in identified individuals (Tang, Paul C. Md, Ms, Mary Ralston, Phd, Michelle 
Fernandez Arrigotti & Lubna Qureshi, Ms, Justin Graham, Md, 2007). The researchers did not 
comment on the correctness of either extraction approach, but instead highlighted the 
discrepancies in quality reporting resulting from either approach. 
 While inconsistencies exist in quality measurements between claims-based and EHR-
based reporting, this inconsistency may become problematic when the language used to classify 
diseases changes from ICD-9 to ICD-10. On January 16, 2009, the Department of Health and 
Human Services (HHS) published a final rule mandating the use of ICD-10 codes3. This mandate 
went into effect on October 1, 2015. 
The ICD-10 code set is significantly different than ICD-9, allowing for more diagnostic 
specificity, among other things (American Medical Assocation, 2014). Studies evaluating health 
care quality using HEDIS®-type measures that span the ICD-10 implementation date should 
choose measures whose methodologies either do not rely on diagnoses or whose ICD-9-to-10 
mappings are equivalent (Centers for Medicare and Medicaid Services, 2014a).  
 
EFFECT OF EHRS ON QUALITY 
 
 Studies on the effect of EHR use on quality are mixed and tend to be performed before 
the implementation of the EHR Incentive Program and federally certified EHR systems. Of the 







studies showing improvements in quality, most do so in relation to specific EHR functionalities 
or regarding guideline-based quality metrics. 
 Using a mail survey and historical HEDIS® State-based data, Poon et al. found 
statistically significant differences in quality scores for certain quality measures based on 
specific EHR functions (Poon et al., 2010). The authors found positive correlations between 
EHR functionalities of problem lists, visit notes, and radiology test results and quality 
measurements for women’s health, cancer screening, and cancer prevention (Poon et al., 2010).  
Using a matched mailed survey data to State-based HEDIS® data, Zhou et al. found no 
statistically significant association between EHR use and the quality reporting for six different 
HEDIS® measure (2009). Theorizing that the duration of EHR use may increase the likelihood 
of higher quality scores, the authors applied longitudinal data, measuring the average HEDIS® 
score across EHR users over time. Regression analysis showed no statistically significant 
association between quality performance and duration of EHR use (Zhou et al., 2009). 
 Perhaps the most directly applicable source of quality improvement available to an EHR 
is clinical decision support (CDS). CDS varies in scope, but generally provides clinical 
reminders to care givers about specific treatment recommendations, but may also be more 
complex, linking problem lists as well as invoking practice guidelines (Ohno-Machado, 2011). In 
a systematic literature review, Chaudhry et al. noted that health information technology in 
general might best improve quality through its adherence to guideline-based care (Chaundhry et 
al., 2006). Shojania et al. performed a systematic literature review of studies whose intervention 
involved on-screen computer reminders delivered at the point of care, used randomized or quasi-
randomized study design, and had at least one clinical or clinical adherence-based outcome 





median improvement of 4.2 percent across all process-based quality metrics, and a 3.8 percent 
median improvement for vaccinations (Shojania et al., 2009). 
 Welch et al. noted only a slight positive impact on quality comparing physicians who did 
not use an EHR with those that had, but these gains only appeared for hypertension and 
hyperlipidemia (Welch, Pete W., Bazarko, Dawn, Ritten, Kimberly, Burgess, Yo, Harmon, 
Robert, Sandy, 2007). However, the authors only analyzed information on four practices, with 
each having varying levels of decision support. In a larger study using a nationally representative 
sample of ambulatory care visit data between 2005 and 2007, Romano and Stafford did not find 
a consistent improvement in quality scores comparing EHR users with decision support to non-
users (Romano & Stafford, 2011). The authors hypothesized that decision support would lend 
itself to quality improvement among certain conditions with clear guidelines. Poon et al. used a 
cross-sectional study design of survey data and found no significant difference in the majority of 
quality indicators for EHR users versus non-users (2010). Although the authors found higher 
quality scores for EHR users in two areas, they found decreased quality scores in another. 
 The literature relating quality to EHR use suggests that quality improvement may have a 
greater probability of occurring if the EHR functionality links closely with the quality metric and 
if providers effectively use the functionality. Using a retrospective cross-sectional study of 65 
providers eligible for the EHR Incentive Program and practicing within an outpatient network of 
Federally Qualified Health Centers (FQHC) in New York, Ancker et al. found that those 
providers who used the functionalities of best-practice alerts, order sets, and panel-level 
reporting, received statistically significantly higher “meaningful use” quality scores related to the 





CDS for the preventative services of tobacco cessation, breast cancer screening, colorectal cancer 
screening, pneumonia vaccination, and body mass index screening (Ancker et al., 2015).  
Although decision support may be the most likely function of an EHR to elicit an 
improvement in quality, the application of decision support to clinical practice is dependent upon 
the availability of clear clinical guidelines. Clear clinical guidelines are available for diseases 
such as asthma, diabetes, and vaccinations. And, based on randomized control trials, researchers 
showed improvements in adherence to many care guidelines (Bell et al., 2010; Trial, Gilmer, & 
O’Connor, 2011). 
Childhood immunization schedules are an example of guideline-based care that can be 
facilitated by HIT functionality such as parental reminders and CDS. Parental reminders and 
CDS use the vaccine schedule and information about the patient to trigger an action by either the 
patient (parental reminders) or the provider (CDS).  
Before the availability of HIT, providers and public health advocates relied on 
reminder/recall interventions such as telephone or mail, and later text messaging and email to 
improve patient follow up for care (Stockwell & Fiks, 2013). In the area of vaccinations, this 
outreach is used to remind patients of an upcoming or missed vaccination. Szilagyi et al. found 
that missed opportunities for vaccinations are a leading cause of under-vaccination in preschool 
children, particularly those on Medicaid (P G Szilagyi et al., 1993).  
Increasingly, EHR vendors offer text messaging and emailing as a means to engage 
patients. A systematic review of text messaging as an intervention for pediatric care found 
significant effects in 71% of studies, particularly for vaccine-based interventions (Militello, 
Kelly, & Melnyk, 2012). Text-message interventions may be particularly influential in low-





providers when surveyed (Stockwell & Fiks, 2013). Unlike text messaging, email reminders 
provide less-definitive results, due in part to the low number of studies investigating their impact 
(Stockwell & Fiks, 2013). 
Unlike reminder/recall interventions, EHR CDS focuses on prompting the provider to 
take some type of action on particular patients, usually during or immediately surrounding the 
patient encounter. CDS may be effective as a childhood vaccine intervention because it takes 
advantage of the presence of the child during well- and sick-child visits to reduce the likelihood 
of missed opportunities to administer or catch up on vaccines. The Advisory Committee for 
Immunization Practices for the CDC’s vaccine schedule lays out when vaccines should be 
administered and the time period to receive “catch up” vaccinations if necessary. From 0-18 
months, a child should receive about 10 vaccinations, depending on dose or combination; and, 
depending on what dose is scheduled, missing a single opportunity to immunize could reduce the 
effectiveness of previous doses of a vaccination or prevent immunization from other viruses. 
Using a historical medical records review of children throughout the United States, Fu et al. 
found that patients who had any missed opportunity for a vaccination were 3.5 times more likely 
to be under-immunized compared to those who had no missed opportunities (Fu et al., 2015).   
Further, because the age of the child and their immunization status determine their place 
on the immunization schedule, some missed opportunities to immunize are more significant than 
others. By reviewing the 2006-2007 National Immunization Survey, Luman and Chu found that 
about 20 percent of children fell behind their scheduled vaccinations between months 7 and 16, 
mostly due to the vaccine schedule’s requirement for simultaneous vaccination during this 





Vaccine-based CDS interventions may improve vaccine rates, but intervening factors 
such as the implementation of CDS within provider work flow and alert fatigue may dampen 
CDS’s impact on vaccination rates.  For vaccine-based CDS, EHRs tend to provide alerts at the 
point of care, notifying the provider that a patient is due for a particular vaccine (Stockwell & 
Fiks, 2013). Based on a systematic review of on-screen, point-of-care implementation of 
vaccine-based CDS in diverse practices seeing adults and children, Stockwell and Fiks found a 4 
percent increase in the ordering of recommended vaccines (2013).  
However, Sittig et al. (2009) and Osheroff et al. (2007) note that while CDS may be a 
way to increase the vaccination rate, implementation of CDS in accord with the provider’s 
workflow is important for improving effectiveness (Osheroff et al., 2007; Sittig et al., 2009) . If 
not implemented appropriately or combined with too many alerts, an alert-based CDS may not 
be effective (Peter G. Szilagyi et al., 2015). For example, within a single hospital-based network, 
Fiks et al. showed an increase in HPV vaccine rates from a prompt-based CDS practice 
compared to a control (2013). Further, in a one-year study across a primary care network 
implementing CDS alerts with direct access to immunization order sets for well- and sick-child 
visits for all children under 24 months compared to historical controls, Fiks et al., found 
statistically significant increases in immunization opportunities and immunization rates (Fiks, 
Grundmeier, Biggs, Localio, & Alessandrini, 2007).  In a separate setting, Szilagyi et al. found 
no improvement in vaccine rates for adolescents in 24 New York primary care practices 







APPROACHES TO STUDYING THE EFFECTS OF EHR USE ON QUALITY 
 
  Studies evaluating the effectiveness of EHRs either take a cross-sectional or longitudinal 
approach using a pre-post design. Major independent variables include physician characteristics 
such as age, gender, degree, specialty (primary care provider versus specialty care), country, 
practice size, and adoption of practice management system (Kern, Barrón, Dhopeshwarkar, 
Edwards, & Kaushal, 2013; Keyhani et al., 2008).  Additional independent variables such as 
patient panel size per physician and case mix of patients are also used (Kern et al., 2013). Case 
mix can be estimated using patient-level diagnosis obtained from administrative sources 
maintained by health plan insurers.  
  Researchers generally use a dichotomous variable for the presence (or absence) of an 
EHR as the active independent variable. Researchers tended to operationalize EHR use in this 
way because of the difficulty of generalizing EHR products within study participants and to the 
general population as a whole. Prior to the HITECH Act, EHRs tended to be “home-grown”: 
designed with practice-specific functions. Because practices created EHR products to meet their 
own needs, most studies attempting to measure the impact of EHR use on quality could not 
create similar groups of EHR (the intervention group), and therefore isolate particular qualities of 
EHRs with which to correlate an outcome, such as quality. With the increased standardization of 
EHR products under the HITECH Act and its creation of EHR certification bodies (45 CFR Part 
170), it may be easier for researchers to distinguish EHR types and to correlate and generalize 
EHR use with quality.    
  Although certification bodies improved the likelihood that all EHRs would contain 
similar functionalities, such as electronic prescribing (e-Prescribing) or clinical decision support 





different ways, or not at all. Some EHRs come as modules – interconnected functional 
components or features obtained from different vendors – or as complete systems (“monolithic”) 
by the same vendor. Further, the hardware for either monolithic or modular systems can be 
housed locally or remotely. A practice’s decision to select one of these four types of EHRs may 
have an impact on practice workflow (see Fleming et al., 2014), which, in turn, may have an 
impact on health care quality. 
  Researchers focusing on the effect of EHR on quality often use a standardized quality 
metric as the dependent variable, such as the National Committee for Quality Assurance’s 
(NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®).  HEDIS® offers 75 
standardize process and quality metrics across eight domains to compare health care plans. These 
metrics often calculate the percent of eligible patients for a given domain receiving best-practices 
care. 
  Two approaches to using HEDIS® measures as an outcome variable include focusing on 
a handful of provider-specific measures, such as adherence to best-practices guidelines, to 
measure the proportion of patients who receive that care who were eligible for it or using 













 This chapter begins with a discussion of my hypothesis and the conceptual framework 
which informs the hypothesis. Next, I discuss the study design and the causal model. I then 
provide an overview of the data, particularly data collection and integration. With the data as a 
backdrop, I then discuss the study population and sample selection process, the data cleaning 
process, the results of propensity score matching (PSM) used to create the control group, and 




 According to Donabedian, health care quality can be evaluated based on three 
interconnected areas: structure (the system), process (the activities), and outcomes (the results) 
(1966). Health care providers adopting an EHR system will likely face a change in their 
workflow; and this change may impact process, and by extension, quality.  
The literature around the impact of EHR implementation on productivity is mixed. 
Studies show a perceived negative impact on productivity from health care providers, potential 
improvements to productivity, and decreases in productivity for a limited period of time, 
followed by increases after an initial ‘ramp up’ period (Cheriff, Kapur, Qiu, & Cole, 2010). 
Further, health care provider staff buy-in and technical capability may play a distinctive role in 





Based on the above, I hypothesize that following the intervention, a provider who 
adopts an EHR will have an increase in their quality score. Because health care providers 
may experience various issues related to fully utilizing their EHR during the “ramp-up” period 
which will be difficult to capture in the analysis, this research creates an aggregated 




  As the technical components of the health care system have become more complex, Sittig 
and Singh argue that it is increasingly more difficult to identify a conceptual model to study 
Health IT interventions (Sittig & Singh, 2010).  The authors argue that studies evaluating the 
effectiveness of Health IT interventions fail to capture how the system and its features interact 
with both the individuals who use the system and the context in which the system is both 
acquired and used.  In their conceptual model, eight sociotechnical domains are used to evaluate 
the effectiveness of HIT systems: (1) Hardware and software computing infrastructure; (2) 
clinical content; (3) human-computer interface; (4) people; (5) workflow and communication; (6) 
internal organizational policies, procedures, and culture; (7) external rules, regulations, and 
pressures; and (8) systems measurement and monitoring (Sittig & Singh, 2010).    
  A systematic literature review by Sockolow et al., took a health services research 
approach to HIT evaluation (Sockolow, Bowles, Lehmann, Abbott, & Weiner, 2012). The 
authors’ review built upon Ammenwerth and deKeizer’s framework and resulted in a HIT 
Reference-based Evaluation Framework (HITREF) with six dimensions of HIT comprised of 
various evaluation components. Figure 2 depicts the six dimensions ((1) Structural Quality; (2) 





Outcome Quality of Care; (5) Effects on Quality Processes; and (6) Barriers or Facilitators to 
Adoption) and its evaluation components. The model, thus, is a health-services variant of the 
Technology Acceptance Model (Davis, 1989). 
 
   
 






  This framework is preferable to Sittig and Singh in that it broadens the contextual 
relationship between the HIT system and its stakeholders (Sockolow, Bowles, Lehmann, Abbott, 
& Weiner, 2012). Each of the six dimensions feed into user satisfaction with the HIT system, and 
each of the six dimensions have particular multi-dimensional evaluation components. 
  As a tool for guiding research into the effects of EHR on quality, the HITREF highlights 
the importance of contextual factors, such as the type of EHR system used and its usability by 
practitioners (dimensions Structural Quality and Quality of Information Logistics), as well as the 
implementation of that system within the general practitioner workflow (Effects on Outcome 
Quality of Care; Effects on Quality Processes). Further, the characteristics of the providers and 
patients making up the implementing practice will also influence the satisfaction and use of the 
system.  
  To inform my research, I conceptualize the source and target models depicted in Figure 3. 
The overall theory is that EHR use leads to increases in quality. According to this model, 
“Meaningful Use” is a proxy for “Electronic Health Records Use” and the Childhood 










 To understand the association between EHR use and the quality of health care delivered, 
this research uses an interrupted time series (ITS).  An interrupted time series is a quasi-
experimental research design with a pre- and post-intervention period, where the intervention can 
be a policy or program implemented to change an outcome (Penfold & Zhang, 2013). Figure 4 
depicts the ITS for this research.  Solid boxes represent measurement periods for either HEDIS® 
scores or “Meaningful Use” for either the intervention or comparison group. The first 
observation begins in 2010, a full year before Maryland began the Medicaid EHR Incentive 
Program. Providers selected as the intervention group adopted their EHR in either 2011 or 2012 







Figure 4: Research Design for Studying the Effect of EHRs on Quality 
 
The outcome measure – immunization status score – is measured by combining the 
individual-level status score for both 2013 and 2014, the “exposure” and “post-exposure” 
periods, respectively. To account for prior experience with EHR or EMR, I will use Maryland’s 
Physician Licensure Database to ascertain whether the provider used an EHR or EMR from 2009 
through 2012. Previous EHR or EMR use is restricted to 2009 because this is the first year that 
the Maryland Physician Licensure survey included this question. 
Due to Medicaid EHR Incentive Program participation rules – which only allow a 
provider to participate in the Program once per year – this study will apply a one-year 
measurement pause or “contamination buffer.” The “contamination buffer” is necessary because 
providers who have achieved “Meaningful Use” in calendar year 2013 likely acquired their EHR 
in calendar year 2012. However, the provider who acquired their EHR in 2012 could have done 





workflow and quality reporting, and the magnitude and duration of this impact will likely depend 
on the date on which the provider implemented the system, and the exact date of EHR 
implementation is not known, I will not use outcome measures during this year in the analytic 
model. However, this data will be used to during propensity score matching since it is collected 
before the intervention period.  
Figure 5 shows this research design graphically, including the hypothesized results. To 
simplify the hypotheses, Figure 5 depicts a hypothetical scenario with a steady rate of average 
HEDIS® score growth for the comparison group over the time horizon of this study. The actual 




Figure 5: Hypothesized Graphical Representation of Study Results 
 
The hypothesized results are that after acquiring an EHR and accounting for a 
contamination period of one year, providers’ quality scores will increase. The Y-axis displays 
the average quality reporting for the intervention group (managed care network provider “EHR 
































not analyzed in this study, during the year of EHR acquisition (2012), the intervention group 
may experience a decrease in quality due to factors related to the “ramp-up” period, while the 




Using the HITREF framework to identify dimensions affecting successful Health IT 
implementation and the source and target model diagram to inform the research approach, Figure 
6 depicts the causal model of variables impacting the main hypothesized relationship between 
“EHR Use”, “Increased Quality”, and “Increased Combination Immunization Score.” As detailed 
in the “Variables and Measures” section below, I will take each variable depicted in Figure 6 into 
account when building my analytic model. EHR Use – as measured by “Meaningful Use” 
(“MU”) – leads to increased immunization rates (“Increased Quality”), as measured by an 






Figure 6: Presumed Causal Model of Variables Affecting the Relationship  
Between EHR Use and Quality Scores 
 
 
The provider’s “HEDIS® Combo. Measure” is a Maryland-specific VBP initiative that 
combines the immunization rates for DTaP, IPV, MMR, HiB, HepB, VZV, and PCV 
(Combination 3) and is pursued by every Maryland MCO. Because the “HEDIS® Combo. 
Measure” is a subset of the HEDIS® Combination Score, this analysis uses the combo measure 
to “check” on the relationship between EHR Use and the HEDIS® Combination score. If an 
individual’s HEDIS® combo measure affects the relationship between EHR Use and the 





 Motivational confounders, such as participation in VBP, the Vaccines for Children (VFC) 
program, and State-Regulated Payor EHR Adoption Incentive Program, may all impact the 
relationship between EHR use and quality, and thus must all be controlled for in the analysis. 
Many other incentive-based programs may exist for providers, such as the MHCC-administered 
Patient Centered Medical Home (PCMH), which, if not controlled for, may introduce bias. 
However, I could not obtain this information. As discussed in the Strengths and Weaknesses 
section, I attempted to mitigate this bias through the study design. 
Although all MCOs participate in the VBP, MCOs may place different focus on various 
quality-improvement programs, such as immunization rates. Thus, a provider’s MCO network 
affiliation may act as a confounder between a provider’s immunization quality score and the 
presence of an EHR.  This study does not control for the specific MCO that a provider 
participated with during the study period, nor the recipient’s MCO affiliation. The reason I chose 
not to control for MCO affiliation is because of our focus on the provider as the unit of analysis. 
If I had introduced MCO affiliation at the provider and patient level, I would be analyzing the 
impact of the MCO and provider relationship on immunization status. Instead, this study 
analyzes the relationship between MCO network providers -- regardless of the specific MCO 
affiliation -- and the provider’s patient panel recipient vaccination rates. 
The VFC program provides free vaccines to providers in exchange for Maryland 
providers agreeing to follow childhood vaccine schedules. Thus, the providers participating in 
the VFC program can obtain all vaccines measured by the HEDIS® Immunization Status Score. 
The availability of this program may create an incentive for vaccine administration, both for the 





Administered by MHCC, the State-Regulated Payor EHR Adoption Incentive Program 
required that State-regulated health care payors offer incentives to primary care practices for 
adopting and using certified EHR technology. Until 2014, the incentive included an $8 per 
member base incentive up to $7,500 per payor for the adoption of EHR technology. If the 
practice demonstrated advance use of the technology, they could receive up to an additional 
$7,500 per payor. In 2014, the program changed such that (1) primary care practices must either 
meet Meaningful Use or participate in any MHCC-approved Patient Centered Medical Home 
(PCMH) program and achieve NCQA PCMH recognition, and (2) the incentive would be 
calculated based on a $25 per member amount not to exceed $15,000 per practice per payor. 
The longitudinal nature of the research design will allow for the controlling of PCMH and State-
Regulated Payor EHR Adoption Incentive Program participation (Maryland Health Care 
Commission, 2018).  
 Additional variables impacting the relationship between EHR use and quality include 
EHR type and Meaningful Use reporting period. Different EHRs may be more adept at aiding 
providers in meeting quality metrics due to usability. Further, depending on the time in which the 
provider adopted and then implemented their EHR in relation to their Meaningful Use reporting 
period may create an exposure confounder.  
 
DATA AGGREGATION MAP 
 
 Building upon the analytic model depicted in Figure 6, Figure 7 provides a data 
aggregation map depicting the process I used to create the data set used in our analytic model. 





data steward, the data from each source I used in this analysis, and any software used to query or 
aggregate the data.    
Throughout the  remainder of Chapter 3, I will refer to Figure 7  when describing each 
step in the data cleaning and aggregation process. I will make references to Figure 7 using the 
numbered circles. 
 
SOURCES OF DATA AND DATA STEWARDS 
 
 To obtain data for this study, I queried databases maintained within the Maryland 
Department of Health, the State of Maryland’s Board of Physician’s Database, and the Maryland 
Health Care Commission (MHCC). MMIS is Maryland Medicaid’s claims payment and 
processing system. The system contains claims and encounters data and is used to calculate 
HEDIS®-type measurements for the Value-Based Purchasing (VBP) program (Figure 7, ). 
Data related to the EHR Incentive Program, including participation, EHR type, and 
Meaningful Use measures is obtained from Maryland’s EHR Incentive Program Registration and 
Attestation System, the eMIPP system (Figure 7, ). 
The Maryland Board of Physician’s Database contains licensure and survey data on all 
physicians licensed in Maryland. This data source is used to obtain demographic information on 













The Vaccines for Children Program (VFC) is administered by the Center for 
Immunization within the Prevention and Health Promotion Administration, an administration 
under the Maryland Department of Health (Figure 7, ). This data base contains data on 
provider immunization administration and participation in the VFC. 
Since the MHCC is charged with operating the State-Regulated Payor EHR Adoption 
Incentive Program, data on provider participation and year of participation is obtained from the 
MHCC (Figure 7, ). 
The Healthy Kids Program is Maryland’s Early Periodic Screening, Diagnosis, and 
Treatment (EPSDT) Program. State-employed nurses visit pediatricians enrolled in Maryland 
Medicaid to certify them as meeting EPSDT standards, entering provider data into a local 
database overseen by the Maryland Department of Health (Figure 7, ). 
 
PROPENSITY SCORE MATCHING 
 
 Because this research is observational and uses a quasi-experimental research method, I 
do not have a clear control group. One method for establishing a control group for quasi-
experimental research designs is propensity score matching (PSM) (Figure 7,). PSM models 
the conditional probability of being selected for the treatment group given a series of 
confounders related to the outcome but not the treatment (Brookhart, Alan M., Schneeweiss, 
Sabastian, Rothman, Kenneth J., Glynn, Robert J., Avorn, Jerry, Sturmer, 2006; Rosenbaum, 
Paul R., Rubin, 1983). In observational studies where an intervention does not have a clear 
control group, such as would be the case with a randomize control trial, PSM can help to match 
observed pre-treatment assignment variables of individuals in the treatment group to those of a 





of the treated and a control group, I may improve the likelihood that differences in outcome 
between intervention and control groups are due to the intervention alone and not unmeasured 
covariates. In other words, the more similar the intervention and treatment group are to each 
other on various characteristics before treatment, the more likely I am confident that I can better 
infer causal inferences between treatment and outcomes (Kaplan & Chen, 2012). 
 
VARIABLES AND MEASURES 
 
  The variables used in this analysis, including their description, type, and sources, are 
listed in Table 1. A more detailed description of each variable and its measure are described 
below. 
 
Table 1: Variables, Description, Type, and Source 
 
Variable Type Description Data Type Source 
Dependent 




(Figure 7, ) 
Independent 
Achieving Meaningful Use in the 
Medicaid EHR Incentive Program  
Binary 
eMIPP 
(Figure 7, ) 
Covariates 
Provider Specialty Categorical 
MMIS 
(Figure 7, ) 
Practice Medicaid Patient Volume Nominal 
MMIS 
(Figure 7, ) 
Outpatient Visits Nominal 
MMIS 
(Figure 7, ) 




(Figure 7, ) 
Medicaid Child Case Mix  
(% of total Medicaid patients) 
Proportional 
MMIS 
(Figure 7, ) 
Participation in the State-Regulated 




(Figure 7, ) 
 
 












Variable Type Description Data Type Source 
Healthy Kids (EPSDT) Participation Binary 
MDH 


















  The main outcome measure of “quality” is measured using an ambulatory provider-based 
version of the HEDIS® objective for childhood immunization status.  This measure is expressed 
as a percentage of all eligible recipients during the year who receive various immunizations. The 
outcome measure used in this study is a version of Combination Measure 7, which requires that 
the following vaccines be administered before age 2: four diphtheria, tetanus and acellular 
pertussis (DTaP); three polio (IPV); one measles, mumps and rubella (MMR); two H influenza 
type B (HiB); two hepatitis B (HepB)4, one chicken pox (VZV); four pneumococcal conjugate 
(PCV); two hepatitis A (HepA); and two or three rotavirus (RV). 
I chose the childhood immunization quality metric because of the consistency of its use in 
the VBP program, its direct link to a Meaningful Use clinical quality measure, and the 
consistency in the Medicaid population during Health Care Reform.5  Maryland Medicaid has 
                                                 
4 HEDIS requires three Hep B vaccinations before age 2; however, this analysis only requires that a child receive 
two. See Table 2. 
5 As a result of the Affordable Care Act, States had the option to expand their Medicaid population to cover childless 
adults.  Maryland Medicaid chose to participate in this expansion. The Medicaid expansion population of childless 
adults will likely not affect the childhood immunization measure, which is only applicable to children under age 2. 
HEDIS®: Healthcare Effectiveness Data and Information Set 
MMIS: Medicaid Management Information System 
eMIPP: electronic Medicaid Incentive Payment Program 
EHR: Electronic Health Record 
BoP: Maryland Board of Physicians 
MHCC: Maryland Health Care Commission 
MDH: Maryland Department of Health 







used this quality measure since at least 2009, and this quality measure is 1 of 7 VBP-based 
HEDIS® measures, making it financially important for Maryland Medicaid MCOs to ensure that 
their providers provide childhood immunizations. Further, because the childhood immunization 
quality metric does not rely exclusively on diagnosis codes, this study can be replicated 
longitudinally during the ICD-10 implementation period.  
  Table 2 lists each vaccination, the current procedural terminology (CPT) codes identified 
by HEDIS® to indicate the administration of each vaccination, and any details about vaccine 
administration or how its administration may have changed within the years of the study period, 
2010-2014. All data used to calculate the outcome measure comes from MCO encounters 
submitted to the MDH over the study period (Figure 7, , “Encounters”). 
 
Table 2: Computable Phenotype Used to Identify Immunization Administration 
 
Immunization CPT Codes Notes 
DTaP 90698, 90700, 
90721, 90723 
At least four vaccinations, with different dates of service on or 
before child’s second birthday. Do not count any vaccines 
administered prior to 42 days after birth. 
IPV 90698, 90713, 
90723 
At least three vaccinations, with different dates of service on or 
before child’s second birthday. Do not count any vaccines 
administered prior to 42 days after birth. 
Measles, Mumps, and Rubella (One of the below options) 
























At least two vaccinations with different dates of service on or 
before child’s second birthday (due to shortage).  
Hep B* 90723,90740, 
90744, 90747, 
90748 
At least two vaccinations with different dates of service on or 
before child’s second birthday.  






At least four vaccinations, with different dates of service on or 
before child’s second birthday. Do not count any vaccines 
administered prior to 42 days after birth. 
Hep A 90633 For 2010 - 2012 
Two vaccinations with different dates of service on or before 
child’s second birthday. 
 
For 2013 and 2014 
One dose on or before child’s second birthday. 
Rotavirus (One of the below) 
Rotavirus 2 90681 Two vaccinations with different dates of service on or before 
child’s second birthday. Do not count any vaccines administered 
prior to 42 days after birth. 
Rotavirus 3 90680 Three vaccinations with different dates of service on or before 
child’s second birthday. Do not count any vaccines administered 
prior to 42 days after birth. 
 
 
*HEDIS and Maryland’s Healthy Kids program specifies three vaccinations. However, because the first dose 
frequently occurs at birth within the hospital, and this analysis is measuring vaccine rates associated with 
PCPs in an office-based setting, the number of minimum vaccines required is reduced to two. 
†In mid-2011, CDC recommended the use of PCV13, documented with CPT code 90670.  New conjugate 





  Some children may not receive vaccinations due to contraindications. Vaccine 
contraindications are conditions that increase the risk that a patient will experience a severe 
adverse reaction to the administration of a vaccine. Based on the diagnosis codes listed in Table 
3, children are removed from the denominator of specified immunization HEDIS® scores. To 
account for contraindications, I searched Medicaid MCO encounter history for the diagnosis 
codes listed in Table 3 from any recipient’s prior Medicaid encounter history. Since each child’s 
immunization status is checked from birth through age two, this means that encounter history is 
searched for contraindications for any date of service from 2009 through 2014. If a Medicaid 
encounter contains any ICD-9 code listed in Table 3, that child is removed from the denominator 
of the mapped immunization. 
 
Table 3: Contraindications for Children Eligible to Receive Vaccinations 
Immunization ICD-9 Code 
DTap 323.51 with (E948.4 or E948.5 or E948.6) 
MMR, VZV 279 or 042 or V08 or 200-208 
 
 
  Between 2010 and 2014, Maryland MCOs averaged a 36.8 percent reportable rate for 
Combination 7 (HealthcareData Company, 2014). This relatively low compliance rate compared 
to a theoretical 100 percent reportable rate reduces the likelihood that participants in this study 
will experience a “ceiling effect” during the study period. MDH’s contractor, HealthcareData 
Company, LLC, collects, calculates, and reports Maryland Medicaid’s HEDIS® scores.  All 
measures collected follow national standards, which allow for cross-plan comparisons. The 





  Although Maryland collects HEDIS® data on 21 measures a year, only a handful of 
HEDIS® measures are used for the Department’s VBP program. Immunization Status Score, 
Combination 7 is not one of the 10 quality metrics used by MDH’s VBP; however, the MDH 
does include Immunization Status Score, Combination 3. Due to the financial incentive and 
disincentive associated with immunization administration, there is likely to be greater attention 
paid to the accuracy and completeness of relevant data among MCOs and their network 
providers. To check the reasonableness of the HEDIS® scores calculated, I referenced the 
Maryland MCO HEDIS® Combo 3 and Combo 7 scores for each study period. 
 
Active Independent Variable 
 
  Active independent variables include a binary variable on whether a provider 
implemented an EHR and received payment for participating in Maryland Medicaid’s EHR 
Incentive Program in 2013. Depending on the type of EHRs used and whether there is any 
variability between quality and EHR type, this study utilizes a categorical variable for EHR 
vendor deployment type, either cloud-based, client/server-based, or both.6  To identify Medicaid 
providers who have implemented an EHR, this research uses the data from Medicaid’s EHR 
Registration and Attestation System (eMIPP) (Figure 7, ). This data repository stores 
information on participants in the EHR Incentive Program. 
  The reliability and validity of EHR Incentive Program Year participation and EHR 
Certification Number, vary. The binary variables for EHR implementation and EHR system are 
based on self-reported data by providers during the attestation process for participation in the 
                                                 
6 To categorize the type of EHR implemented, I used the eMIPP system and an EHR Certification Number 
crosswalk that maps the certified system to a product description. The CMS Certification Number is a unique 15 
alphanumeric string that identifies the EHR product as “complete” (“monolithic”) or “complete because of 
additional modules” (“modular”). Because all providers in the intervention group use complete/monolithic products, 





Medicaid EHR Incentive Program. Although some providers may be audited for the validity of 
their attestation, this research does not take this into account. Thus, it is assumed that all 
providers who attest to implementing an EHR have actually done so. It is also assumed that the 
provider correctly selects their CMS Certification Number.  However, there is likely no 
difference between the likelihood of any one provider or provider type to misreport this 
information, thus the reliability of both variables is likely sound. 
 
Intervening Variables (Non-Propensity Score Matching Variables) 
 
  The non-Propensity-Score-Matching variables that act as intervening variables – 
participation in the State-Regulated Payor EHR Adoption Incentive Program, prior EHR use, and 
predominant health care group affiliation – are obtained from various sources and are likely 
reliable and valid measures.  
  The Maryland Health Care Commission (MHCC) provided data used to ascertain 
participation in the State-Regulated EHR Incentive Program by year, using the data listed in 
(Figure 7, ). The HEDIS® immunization status score used as a check on the outcome measure 
is obtained from administrative data published by MDH following a review by the Department’s 
measure validation vendor, Healthcare Data Company LLC. Primary provider group affiliation is 
derived from MMIS (Figure 7, ), using an iterative approach described elsewhere in this 
research. 
  Provider participation in the State-Regulated EHR Incentive Program, the EHR Incentive 
Program and with MCOs are controlled by contracts, impact payments, and are subject to post-
payment audits, so information contained in these databases will be accurate. HEDIS® 
Combination Scores are rigorously reviewed before being approved by MDH and are thus likely 





must produce Meaningful Use reports to substantiate that they have met Program requirements. 
These reports are submitted to Medicaid during attestation. 
 
Propensity Score Matching Variables 
 
  The provider-level characteristics of specialization, Vaccines for Children (VFC) and 
Healthy Kids (EPSDT) participation, and group size and child visit caseload are available from 
MCO and Medicaid Fee-For-Service (FFS) administrative and claims data, respectively (Figure 
7, ). This information should be both reliable and valid, as all are required elements to finalize 
contracts between the MCO and the provider. Additionally, claims data, which is used to 
calculate case load, is reliable and valid, as it results from robust pre-payment validation checks 
against both provider and recipient data. Provider specialty is also crosschecked with the State 
Licensure Board during MCO enrollment, and when there is a conflict with provider specialty 
across MCO or time, I cross-referenced the provider’s National Provider Identifier (NPI) against 
the Center for Medicare and Medicaid Services National Plan and Provider Enumeration System 
(NPPES). 
  Percent of Medicaid patient case mix is expected to be reliable and valid. Medicaid FFS 
pre-payment provider and recipient screening is robust, and its annual post-payment auditing of 
MCO encounters rigorously checks provider and patient information. Although providers must 
submit percent Medicaid patient volume during a typical quarter for the calendar year previous to 
participation in the EHR Incentive Program, this is still a self-reported measure. However, the 
measure is likely reliable across provider types, as there is no reason to believe that any one 






STUDY POPULATION AND SAMPLE 
 
 Thus far, this chapter has described the source of data, its data steward, and data 
elements. This section describes the selection of the study population. The EHR Incentive 
Program pays providers an incentive for adopting and then “meaningfully using” their certified 
EHR. Providers participating in the program can be any non-hospital-based provider,7 which 
includes those in both solo and group practices. Although individual providers receive the 
incentive, it is the practice that installs the EHR. Thus, there are three levels of data collection, 
occasions (time period), the provider, and the practice. The unit of analysis for this study is the 
provider.  
                                                 
7 The federal agency with rulemaking authority for the EHR Incentive Program, Centers for Medicare and Medicaid 
Services (CMS), defines “hospital-based provider” as any provider who sees over 90 percent of their covered 






Figure 8: Study Sample Selection 
 
As shown in Figure 8, the study population is any Maryland Medicaid MCO primary care 
network physician that is continuously enrolled in an MCO over the four-year study period, 
gives immunizations, adopts an EHR, achieves Meaningful Use in 2013, and reported on Clinical 
Quality Measure (eCQM) NQF 0038 “Childhood Immunization Status” (N=147).  
The providers who attested to meeting eCQM NQF 0038 are compared to primary care 
physicians who give immunizations, but do not adopt an EHR. In Figure 8, the populations that 
will be compared are labeled “Intervention” and “Comparison.” For the Intervention and 






 To operationalize the identification of intervention and comparison group providers I 
performed the following steps, described below and depicted in (Figure 7, ).  
 Providers potentially eligible for inclusion in the intervention group are those physicians 
who attested and received payment for meeting programmatic requirements for the Maryland 
Medicaid EHR Incentive Program in calendar year 2013 and also reported on the electronic 
Clinical Quality Measure (eCQM) NQF 0038 “Childhood Immunization Status” (n=210). Then, 
the National Provider Identifiers (NPI) for these providers are checked against Maryland 
Medicaid’s historic Managed Care Organization (MCO) provider network file to obtain MCO 
network enrollment spans for calendar years 2010, 2011, 2012, 2013, and 2014.  
Mimicking HEDIS® requirements for the “Childhood Immunization Status” 
specifications, the enrollment spans for each NPI are analyzed to select only those NPIs where 
there is no more than a 30-day consecutive lapse in provider enrollment across all MCO with 
which the provider is enrolled. Of these providers, only those who are physicians and are 
designated as Primary Care Providers (PCP) by an MCO are selected. To ensure that only 
individual physicians are eligible to be comparison group providers, I used an Application 
Program Interface (API) call to NPPES to validate provider status and provider type (Figure 7, 
). This process resulted in 147 physicians in the intervention group and a potential 1,272 
providers eligible for the comparison group. Providers are selected for the comparison group 
after Propensity Score Matching (PSM) (Figure 7, ). The study population is restricted to 
physician PCPs, instead of other provider types eligible for PCP designation in Maryland 
Medicaid, such as nurse practitioners, because I only obtained covariates from the Maryland 





 After establishing the intervention and potential comparison group, I identified all 
Medicaid children who turned two years during one of the intervention years (2010 – 2014) 
(Figure 7, ). Following HEDIS® inclusion logic, from this pool of children, each child’s 
enrollment in a MCO is calculated such that those children with more than a 1-month (30 day) 
gap in coverage are dropped. The children who have less than a 1-month gap in coverage are 
sorted based on their earliest Evaluation and Management (E&M), preventative medicine CPT 
code, restricted to only initial preventative medicine visits for ages less than 2. The use of E&M 
codes for passive patient attribution has been used by Medicare for quality reporting in the 
Physician Quality Reporting System (PQRS) (Dowd, Li, Swenson, Coulam, & Levy, 2014).  
Similarly, Pham et al. used the number of billed E&M codes to passively attribute patients to 
primary care physicians in order to analyze care coordination between PCPs and other Medicare 
physicians (Pham et al., 2009).   
 Table 4 provides the descriptions for CPT codes 99381, 99382, 99391, and 99392. The 
CPT codes in Table 4 are used as binding codes to link a recipient to a PCP. I chose these codes 
because they represent the child’s first, outpatient visit with a PCP. Because Medicaid may not 
necessarily confirm that a child’s visit is initial versus periodic (e.g., CPT code 99381 versus 
99391), I included codes 99391 and 99392. However, CPT codes 99391 and 99392 are only used 
to bind a recipient to a PCP if encounter history does not reveal an earlier 99381 or 99382 code. 
The resulting analysis produced 78,922 children affiliated with a unique MCO network 










Table 4: Evaluation and Management Codes Used For Patient Attribution 
CPT code Description 
99381 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the ordering 
of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year). 
99382 
Initial comprehensive preventive medicine evaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the ordering 
of laboratory/diagnostic procedures, new patient; early childhood (age 1 through 4 
years). 
99391 
Periodic comprehensive preventive medicine reevaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the ordering 
of laboratory/diagnostic procedures, established patient; infant (age younger than 1 
year). 
99392 
Periodic comprehensive preventive medicine reevaluation and management of an 
individual including an age and gender appropriate history, examination, 
counseling/anticipatory guidance/risk factor reduction interventions, and the ordering 
of laboratory/diagnostic procedures, established patient; early childhood (age 1 
through 4 years). 
 
 
 Following the binding of children to PCPs, the author bifurcated PCPs into intervention 
and potential comparison candidates. These providers are either (1) providers who participated in 
the Medicaid EHR Incentive Program in calendar year 2013, reported on the electronic Clinical 
Quality Measure (eCQM) NQF 0038 “Childhood Immunization Status,” is a PCP for at least one 
MCO throughout the study period and provides immunizations (the “intervention group”) or (2) 
a physician, designated as a PCP by at least one MCO, and provides immunizations (the “eligible 







DATA CLEANING AND LINKING 
 
 
Selecting Records and Merging Data Sets 
 
  This analysis combines six data sources: Maryland Medicaid Information System 
(MMIS); Maryland’s electronic Medicaid Incentive Payment Program (eMIPP); Board of 
Physicians; State Payor EHR Incentive Program; Vaccines for Children Program (VFC); and 
Healthy Kids, Maryland’s Early Periodic Screening and Detection Program. Each data source is 
identified in Figure 7,  – , with the arrows showing the data linkages. The National Provider 
Identifier (NPI) – a unique, provider-specific identifier, self-attested to by every health care 
provider via the National Plan and Provider Enumeration System (NPPES) – is the primary key 
used to combine all data sets. All source records for each data set utilizes the NPI to track 
records except Maryland’s VFC program.   
  To maintain anonymity during analysis, each recipient Legacy MA Number and provider 
NPI is assigned a randomly generated numeric identifier after the data is linked. 
 
Maryland Medicaid Information System Data  
  
  The base data set is the MMIS data obtained on PCPs, their recipients, and their vaccine 
status. The initial MMIS data query contained 65,534 recipients and 1,711 unique providers. To 
ensure that only individual physicians with NPIs known to NPPES are included in the analysis, I 
used the NPPES Application Program Interface (API) to validate provider type, status (active or 
inactive), and NPI type (Type I (individual) providers only. Additionally, I compared provider 
type and specialty codes across MCOs and with NPPES where necessary to confirm a single 
provider type and specialty for each provider. Inconsistencies between providers’ provider type 





outdated internal Medicaid specialty code or due to the MCO designating a provider’s specialty 
as something other than what the provider enumerated in NPPES. This process reduced the 
number of records to 78,990 recipients and 1,400 unique, physician NPIs. 
  To calculate the outcome measure – the HEDIS-like immunization quality score – I 
obtain the encounter and claims history for all recipients who are linked to PCPs using E&M 
codes. The process of retrieving this information is described above. Recipients are tracked 
within MMIS using Medical Assistance Numbers (MA Numbers or Recipient IDs). Medicaid 
recipients may have more than one MA number; however, all MA Numbers are linked to the first 
MA Number received by a Maryland Medicaid recipient -- a Legacy MA Number. Each time a 
recipient received a particular vaccine at the designed time interval, the PCP associated with that 
recipient is credited with administering the vaccination. By vaccine and by calendar year, the 
counts of recipients assigned to the PCP receiving the vaccine are summed, as are the total 
number recipients assigned to the PCP. Using this process, I can obtain vaccination rates by 
provider by vaccination. To obtain vaccination combination scores, the appropriate vaccine 
counts are summed and a ratio of vaccination to total affiliated recipients by PCP is calculated. 
Equation (1) details the vaccination combination score calculation, with nPatient(PCP) being the 
number of patients associated with a particular PCP. 
 
    (1) HEDIS® Score (PCPi) =



















Maryland’s electronic Medicaid Incentive Payment Program (eMIPP) 
 
  To obtain the intervention group, I queried eMIPP for physicians who attested and 
received payment for meeting programmatic requirements for the Maryland Medicaid EHR 
Incentive Program in calendar year 2013 and also reported on the electronic Clinical Quality 
Measure (eCQM) NQF 0038 “Childhood Immunization Status” (n=588).  Since I wanted to 
analyze only those providers who selected the NQF 0038 “Childhood Immunization Status” 
measure and actually reported administering a vaccination, I removed from the analysis 
providers reporting blank numerators, which reduced the sample to 210. After linking this data 
set via NPI to the claims and encounter query, a total of 147 providers remained. I dropped 63 
providers from the eMIPP file because they failed to meet HEDIS® inclusion criteria or did not 
acquire at least one patient during attribution.  
 
Board of Physicians 
 
  The Maryland Board of Physicians license renewal database provided the following data 
used in this analysis for the years 2009-2014: National Provider Identifier (NPI), Race, EHR use. 
I used the NPI to link records. I used the Race variable as a covariate. For years 2009-2012, the 
Maryland Board of Physicians coded “Race” in a single seven-character string, with each 
character having a binary value of “0” or “1” for whether or not the physician self-reported as 
being a specific race. For the period 2013-2014, the Maryland Board of Physicians changed their 
approach to the “Race” variable but storing the same race numeric string positions in separate 
fields, instead of a single string. Because the position of each race description remained the same 





concatenated race values across all providers and years. Based on frequency distributions across 
these 21 unique race values, I created five categorical race bins, as show in Table 5. 
 
 






White Any physician selecting “white.” 1 44% 
Asian 
Any physician selecting “Asian,” except 





Any physician selecting “Native 
Hawaiian or Pacific Islander”, except 
those selecting either “White” or “Asian.” 
3 16% 
Other All other “Races” 4 4% 
Unknown 
Any provider that did not answer the 
“Race” question. 
5 16% 
   
 
  To determine past use of an Electronic Health Record (EHR), I used the Maryland Board 
of Physician’s licensure renewal survey question that asks at your primary practice location, 
“Are Electronic Health Records (EHR) used?”. The Maryland Board of Physicians used the same 
question, provided the same answer choices, and coded those answers in the same way from 
2009-2014. Providers could choose “All Electronic,” “Part paper and electronic,” “No,” and “Do 
not know.” I coded providers who selected “All Electronic”, and “Part paper and electronic” as 









State Regulated Payor EHR Adoption Incentive Program 
 
  The Maryland Health Care Commission (MHCC) administers the State Regulated EHR 
Adoption Incentive Program. The administrative data collected by MHCC records data on 
provider participation within certain time periods: October 2011-April 2013; May 2013-
December 2013; January 2014-September 2014; October 2014 - March 2015; and April 2015-
September 2015. Due to administrative data collection, it is impossible to determine what month 
or year a provider participated within a given bin. For example, a provider participating in 
November 2011 is indistinguishable from a provider participating in March 2013, since both 
hypothetical providers would show up in administrative data as participating during the period 
“October 2011 – April 2013”.  
  Because this analysis uses calendar year as the standard measurement for all other 
variables, the State Regulated Payor data needed to be divided into calendar year. Additionally, 
because the administrative data are not equitably distributed within or over a calendar year, I 
could only use January 2014 as a natural calendar break point. Thus, I created two binary 
variables for determining participation with the State Regulated Payor EHR Adoption Incentive 
Program, one for the period October 2011 – December 2013 and one for the period January 2014 
– March 2015. Providers participating at any time between October 2011 and December 2013 
are coded with a “1”, all others receive a “0”. Providers participating at any point between 
January 2014 and March 2015 are treated as if they participated only in Calendar Year 2014. 
 
Vaccines for Children  
 
  Maryland’s VFC program uses an Organization Identifier, which tracks the practice 





participation data into the master data set used for this analysis, I de-duplicated VFC 
participation by primary provider contact for each Organization ID. Then, using first and last 
name matches within Microsoft Access, I pulled NPIs from all other data sets. If after leveraging 
current data sets I could not find an NPI, I searched the NPPES registry using the search criteria 
of first and last name and participating state of Maryland. For each calendar year, I assigned a 
binary variable to designation participation in the VFC program. A total of 470 providers could 
be linked to an Org. ID in the VFC data base as participating with the VFC program. 
 
Early Periodic Screening, Diagnosis, and Treatment (EPSDT) 
 
  The Maryland Healthy Kids Program (Healthy Kids) certifies provides EPSDT 
Certification for Maryland Medicaid providers. The Health Kids Program certifies providers 
once, applying a certification date to certified provider records within their native database. 
Using the NPI from this database, I linked providers and determined EPSDT status in the 
following way: Providers receive a “1” in the year they are EPSDT certified and every year 
thereafter. For example, if the Healthy Kids Program certified a provider in 2006, the provider 




All intervention and potential comparison group providers participate with multiple 
groups with a varying number of group members over time. This means that there will be 
varying degrees of confounding among group members of the estimated effect of EHRs on 
quality. Thus, the analytic model chosen must account for group-based confounding. A “group” 





National Provider Identifier (NPI) in Maryland Medicaid. To account for location-based 
confounding, the Medical Assistance (MA) number is used in place of the NPI to establish group 
affiliation (data obtained as shown in Figure 7,  and data linking occurs at ). The MA 
number is a unique 9-digit number that contains a 7-digit base number and a 2-digit location 
code. 
Because providers practice with many groups, and because this analysis recognizes that 
the intervention group is comprised of providers who use an EHR at a physical practice location, 
I restricted each provider in each calendar year to a primary group. For the intervention group, in 
calendar year 2013, the group to which they are primarily affiliated is represented by the pay-to 
MA number to which they released their Medicaid EHR Incentive. For all other periods and for 
all comparison group periods, I used an iterative approach to identify primary group affiliation, 
based off of data in the Fee For Service (FFS) MMIS file. Although this analysis focuses on 
MCO network providers, MCOs do not report to Medicaid the group to which they maintain a 
contract. Rather, they report their networks by individual providers. 
To identify all other primary group affiliations but those for the intervention group in 
calendar year 2013, I queried the FFS MMIS file for any group affiliations. The FFS MMIS file 
records begin- and end-date fields for all group MA numbers to which a provider is affiliated. 
Next, by calendar year, I counted the number of days a provider is affiliated with a group from 
the initial begin date of the group affiliation to the lesser of the date within the calendar year or 
the end of the calendar year. By calendar year, the group with the greatest number of days in 
which the provider is affiliated is marked as the provider’s primary group. In the event that no 
group solely accumulates the greatest number of affiliated days, I next checked for the earliest 





selected the group with a current active billing status with Maryland Medicaid. If the tied groups 
each had an active enrollment status code, I picked the group with the earliest active enrollment 
begin date. If the tied groups each had a current inactive status code, I picked the group with the 
latest inactive begin date.  
Table 6 below shows the descriptive statistics on group membership, comparing the 
intervention group of providers to the PSM-selected comparison group of providers, using the 
method described above. Although group membership affiliation occurred before PSM 
calculation, since group membership was not a covariate for matching, only post-PSM match 
results are shown. Across all years, the individual providers in the intervention and comparison 
groups tended not to be primarily affiliated with any other respective intervention or comparison 
group providers. This is shown by the high frequency of providers with no additional member 
within their respective group. However, if providers were primarily affiliated with other 
respective intervention or comparison group providers, group membership tended to be higher 
among the intervention, as compared to the comparison group.  
Additionally, the number of providers affiliated with a similar group tended to be 
consistent across all time periods for the comparison group; however, for the intervention group, 
the same pattern held true, except for the intervention year, 2013. This collapsing of unique 
group numbers is likely due to the change in methodology for establishing group affiliation in 
this year and the fact that group practices who may not have been the primary practice location 
for intervention group providers moved to claim EHR Incentive Payments from rendering 










Table 6: Descriptive Statistics of Physician Group Affiliations, by Intervention, 










Max. No. of 
Providers per 
Group 1 2-6 7-11 12+ 
CY 2010 
Intervention 112 104 6 1 1 13 
Comparison 138 131 7 0 0 4 
CY 2011 
Intervention 112 104 6 1 1 13 
Comparison 135 125 10 0 0 4 
CY 2012 
Intervention 107 96 8 2 1 14 
Comparison 134 124 10 0 0 3 
CY 2013 
Intervention 63 46 15 1 1 19 
Comparison 135 125 10 0 0 3 
CY 2014 
Intervention 109 98 9 1 1 14 
Comparison 134 125 9 0 0 4 
 
 
Because data are collected at both the provider and practice level, and because different 
providers may participate with the same practice, observations will likely be correlated, leading 
to biased estimates. In multi-level modeling, sample size is important for evaluating standard 
errors both at the individual and group level. For this study, all eligible providers will be 
included, thus reducing the concerns about the individual-level sample. Based on simulations, 
Maas and Hox (2005) note that large group numbers appear more important than large number of 
individuals within groups. Further, standard errors of group-level variances are underestimated 
with groups less than 100, but group numbers between 50 and 100 produce acceptable group-





PROPENSITY SCORE MATCHING 
 
After integrating data sources within Access (Figure 7, ), I created a comparison group 
using R’s MatchIt (http://gking.harvard.edu/matchit) package using the nearest neighbor 
approach, without replacement (Figure 7, ). The Match It package derives a propensity score, 
which acts as a “balancing score,” comparing treatment to comparison. So long as the treatment 
and comparison groups resulting from MatchIt produce balanced data, the resulting treatment 
and comparison panels should reduce the potential for bias, lower variance, and lower mean 
squared error in subsequent analysis using this panel (Ho, Imai, King, & Stuart, 2007, 2011). In 
practice, this means that MatchIt does not produce a treatment-comparison “pair,” but instead 
impanels the data to improve balance between treatment and comparison groups by minimizing 
the difference between treatment and comparison propensity scores. A provider’s score, then, 
summarizes all the measured covariates associated with that provider’s having chosen to use an 
EHR or not, and can be used as a covariate (confounder) in models looking for the impact of 
EHR on HEDIS® scores. 
Koepke et al. used surveys to identify provider and patient characteristic that correlated 
with child immunization rates (2001). Following Koepke et al.’s work, I analyzed provider 
characteristics such as practice size, provider specialty, participation in VFC on childhood 
vaccination rates, finding the strongest correlation with provider type (Koepke, Vogel, & Kohrt, 
2001). For this research, PSM is operationalized by comparing the intervention group to the 
potential comparison group, scoring the likelihood to adopt an EHR matching against data by 
each calendar year on: provider primary group affiliation (calendar years 2010-2012), EPSDT 
certification status (calendar years 2010-2012); provider specialization; participation in the 





years 2010-2012); percent of Medicaid claims and encounter volume for children under 2 years 
of age (calendar years 2010-2012); percent of Medicaid claims and encounter volume between 
the ages of 3 and 18 (calendar years 2010-2012).  
I chose to conduct PSM at the individual provider level (controlling for group 
membership) instead of creating propensity scores at the provider-cross-group level because (1) 
all covariates are obtained at the provider level and (2) the method for and nature of provider 
group affiliation makes it difficult. As explained above, group affiliation is based primarily on 
longevity of affiliation. Because a provider who participates in the EHR Incentive Program could 
receive an EHR Incentive Payment for installation and use of an EHR at any practice at which 
they participate, there is an unknown correlation between group attribution and EHR acquisition 
and use.  Additionally, provider group affiliation and the elective nature of the EHR incentive 
program make it such that a single group could have both intervention and comparison members. 
Finally, as shown in Table 6, the vast majority of groups comprised only one member.  
The MatchIt package provides various methods for determining the type of matching and 
the fitness (or balance) of the comparison group. To determine fitness of the PSM dataset, I used 
either MatchIt  or Cobalt (https://github.com/ngreifer/cobalt) to run a series of balance 
diagnostics, including differences in means, comparing treatment and potential comparison 
groups, a covariate balance chart (“love plot”) comparing absolute mean differences by variable 
pre- and post-matching, and quantile-quantile plots (QQ plots) (Ho et al., 2011). 
The first task was to decide on a match ratio. I evaluated matching approaches using the 
percent balance improvement, comparing the mean distance difference, comparing matched data 
to unmatched data. Using the nearest neighbor approach without replacement, I calculated a 1:1 





balance improvement of the mean distance difference dropped off as the match ratio increased, 
beginning with 98.01for the 1:1 match ratio, 92.94 for the 1:3 match ratio, and 66.05 for the 1:5 
match ratio. 
After selecting the advantageous 1:1 nearest neighbor without replacement match ratio, I 
created QQ plots, comparing the quantiles of the treatment group against the quantiles of the 
matched comparison group (see Appendix 1). These variable-by-variable comparison plots 
generally showed clustering along a straight 45 degree line, providing strong evidence that the 
distributions for the matched treatment and comparison groups are uniform (Ho et al., 2011). 
Calculated in another way, a balance table, compares the mean difference for each 
variable used in matching, pre- and post-matching algorithm. At a 0.1 mean difference threshold, 
only three variables8 remained unbalanced post matching, though the difference in the 
distribution of these values, comparing treatment to pre-PSM matching is not excessive (see 
Appendix 2). 
Figure 9 depicts the propensity score distribution for the 1:1 nearest neighbor approach, 
providing strong evidence that the propensity for selected providers to obtain an EHR based on 
the covariates used in matching are similarly distributed.  
 
                                                 






Figure 9: Propensity Score Distribution, Nearest Neighbor, 
Without Replacement, No Record Discards 
 
 
 Perhaps the best visualization of the impact of PSM on creating a suitable comparison 
group for analysis is a full-variable balance plot. The balance plot in Figure 10 shows each 
variable used in propensity score matching, pre- and post-matching. The dotted line is the 0.1 









Figure 10: Propensity Score Matching Balance Plot 
The narrow spread of the Adjusted points compared with the  
broader spread of Unadjusted points indicates good balance. 
 
 
Table 7 below shows the Welch T-Sample T-test, comparing the means of the matched 
intervention and comparison groups using the preferred 1:1 match ratio file. The large p-values 
denote that there is no statistically significant difference in means, comparing each intervention 
variable mean to its comparison group counterpart, supporting the contention the good balance 
suggested by Figure 10. The final variable list in Table 7, Propensity Score, is a product of the 






PSM matching. The Propensity Score is the probability of each provider adopting an EHR in 
2013 conditional on all other variables used in the PSM model; i.e. the mean propensity for both 
the intervention and comparison group to have an EHR given all covariates used in matching is 
17 percent9 (Adelson, 2013). 
 
Table 7: Variables Used in Propensity Score Matching with 1:1 Match Ratio, Comparing 
Intervention to Comparison Group, Welch Two-Sample T-Test 
Variable 
Group Mean CI 
(p-value) Intervention Comparison 
Provider Specialty† 8.18 7.97 
-0.97 – 0.45 
(0.584) 
VFC Participation* 0.35 0.39 
-0.08 – 0.15 
(0.548) 
EPSDT Participation (CY)*    
2010 0.76 0.78 
-0.76 – 0.12 
(0.678) 
2011 0.82 0.85 
-0.05 – 0.12 
(0.436) 
2012 0.83 0.88 
-0.03 – 0.13 
(0.183) 
Patient Volume (CY 2010)    
Total 4,203 4,092 
-2,027– 1,804 
(0.909) 
 % less than age 2 0.46 0.42 
-0.09 – 0.002 
(0.061) 
% between ages 3 and 18 0.44 0.43 
-0.05 – 0.04 
(0.921) 
Patient Volume (CY 2011)    
Total 4,248 4,415 
-1,817 – 2,151 
(0.869) 
% less than age 2 0.44 0.42 
-0.05 – 0.02 
(0.358) 
% between ages 3 and 18 0.47 0.51 
-0.008 – 0.06 
(0.150) 
Patient Volume (CY 2012)    
                                                 
9 As stated above, “Match It” does not pair treatment with comparison, but instead minimizes the difference between 






Group Mean CI 
(p-value) Intervention Comparison 
Total 4,152 4,554 
-1,574 – 2,379 
(0.688) 
% less than age 2 0.42 0.40 
-0.05 – 0.02 
(0.529) 
% between ages 3 and 18 0.51 0.52 
-0.12 – 0.05 
(0.397) 





  This section provides the descriptive statistics of the data used in this analysis, details the 
model selection, and provides various analyses supporting the chosen model. The descriptive 
statistics show the minimum, maximum, mean, standard deviation and standard error for all 
variables used in the analysis, identified as either treatment, Potential Comparison (PC) group 
and Propensity Score Matching Comparison (PSMC) group. The model selection process uses 
the outcome data of interest – the number of children assigned to each primary care provider 
(PCP) who received the minimum number of vaccination does according to the Combination 7 (a 
“count” of the successes) – to specify either a Poisson or Negative Binomial model. Then, by 
evaluating prior distribution selections, a Chi-square-like calculation, posterior distributions, and 
other diagnostics, I analyze the impact of EHR use on vaccination rates. 
  With the match ratio defined, I have also defined the intervention and comparison groups, 
to whose descriptions I now turn. 
DESCRIPTIVE STATISTICS 
 
 Table 8 below displays the descriptive statistics for the intervention (I), potential 
comparison group, pre-propensity score matching (PC), and the comparison group identified 
† “Provider Specialty” is a categorical variable. 





post-propensity score matching (PSMC). The variables “Provider Specialty” and “Race” are 
categorical variables.   The variables for Vaccine for Children Participation (“VFC 
Participation”), “State Payer EHR Incentive Program Participation”, “EHR Use” based on self-
reported Board of Physicians data, and Early and Periodic Screening, Diagnostic, and Treatment 
participation (“EPSDT Participation”) are binary variables.  “Immunization Status Score” is the 





Table 8: Descriptive Statistics, Intervention (I), Potential Comparison, (PC) and Propensity Score Matching Comparison 
Groups (PSMC)  
 
Variable 
Min Max Mean SD SE 
I PC PSMC I PC PSMC I PC PSMC I PC PSMC I PC PSMC 
Provider 
Specialty¥ 
1 1 1 27 27 27 8.18 8.82 8.00 3.31 3.39 3.28 0.27 0.10 0.27 
VFC Participation  0 0 0 1 1 1 0.35 0.33 0.39 0.48 0.47 0.49 0.04 0.01 0.04 
EHR Use (%)                
2009 0 0 0 0 1 0 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 
2010 0 0 0 1 1 1 0.30 0.23 0.24 0.46 0.42 0.43 0.04 0.01 0.04 
2011 0 0 0 1 1 1 0.32 0.22 0.17 0.47 0.41 0.38 0.04 0.01 0.03 
2012 0 0 0 1 1 1 0.43 0.32 0.34 0.50 0.47 0.48 0.04 0.01 0.04 
2013 0 0 0 1 1 1 0.34 0.26 0.18 0.48 0.44 0.39 0.04 0.01 0.03 
State Payer EHR 
Incentive Program 
Participation (%) 
               
2011-2013 0 0 0 1 1 1 0.05 0.02 0.02 0.23 0.15 0.14 0.02 0.00 0.01 




               
2010 0 0 0 1 1 1 0.76 0.61 0.78 0.43 0.49 0.41 0.04 0.01 0.03 
2011 0 0 0 1 1 1 0.82 0.64 0.85 0.39 0.48 0.36 0.03 0.01 0.03 
2012 0 0 0 1 1 1 0.83 0.67 0.88 0.38 0.47 0.32 0.03 0.01 0.03 
2013 0 0 0 1 1 1 0.83 0.68 0.89 0.38 0.46 0.31 0.03 0.01 0.03 
2014 0 0 0 1 1 1 0.83 0.69 0.90 0.38 0.46 0.30 0.03 0.01 0.03 
Race 1 1 1 5 5 5 2.44 2.26 2.21 1.52 1.45 1.35 0.13 0.04 0.11 
Patient Volume  
(CY 2010) 
               
Total 0 0 0 56,280 99,232 99,232 4,203 2,352 4,092 6,081 5,252 10,097 501.58 148.43 932.80 






Min Max Mean SD SE 
I PC PSMC I PC PSMC I PC PSMC I PC PSMC I PC PSMC 
% between 
ages 3 and 18 
0 0 0 0.78 1.00 1.00 0.44 0.36 0.43 0.16 0.22 0.21 0.01 0.01 0.02 
Patient Volume  
(CY 2011) 
               
Total 58 0 0 48,305 109,079 109,079 4,247 2,430 4,415 5,629 5,480 10,832 464.27 154.87 893.46 
% <age 2 0.12 0.00 0.00 0.77 1.00 0.73 0.44 0.35 0.42 0.13 0.24 0.16 0.01 0.01 0.01 
% between 
ages 3 and 18 
0.15 0.00 0.00 0.76 1.00 1.00 0.49 0.39 0.51 0.13 0.22 0.15 0.01 0.01 0.01 
Patient Volume  
(CY 2012) 
               
Total 128 0 0 21,979 117,491 117,491 4,152 2,480 4,554 4,197 5,477 11,398 346.14 154.78 940.16 
% < age 2 0.06 0.00 0.00 1.00 1.00 0.78 0.42 0.34 0.40 0.14 0.24 0.16 0.01 0.01 0.01 
% between 
ages 3 and 18 
0.00 0.00 0.00 0.87 1.00 1.00 0.51 0.39 0.52 0.15 0.22 0.15 0.01 0.01 0.01 
Patient Volume  
(CY 2013) 
               
Total 2 0 0 35,494 81,373 81,373 4,188 2,167 3,850 5,028 4,484 8,807 414.66 126.72 726.36 
% <age 2 0.00 0.00 0.00 1.00 1.00 0.85 0.41 0.31 0.40 0.16 0.24 0.19 0.01 0.01 0.02 
% between 
ages 3 and 18 0.00 0.00 0.00 1.00 1.00 1.00 0.50 0.37 0.48 0.16 0.23 0.19 0.01 0.01 0.02 
Patient Volume  
(CY 2014) 
               
Total 0 0 0 37,556 89,029 89,029 5,454 2,855 5,16 6,680 5,861 10,4997 550.92 165.64 907.00 
% < age 2 0.00 0.00 0.00 0.98 1.00 1.00 0.39 0.29 0.38 0.17 0.24 0.21 0.01 0.01 0.02 
% between 
ages 3 and 18 
0.00 0.00 0.00 0.83 1.00 0.92 0.50 0.36 0.48 0.18 0.25 0.22 0.02 0.01 0.02 
Immunization 
Status Score 
               
2010 0.00 0.00 0.00 1.00 1.00 1.00 0.17 0.12 0.16 0.24 0.23 0.23 0.02 0.01 0.02 
2011 0.00 0.00 0.00 1.00 1.00 1.00 0.21 0.14 0.20 0.27 0.25 0.26 0.02 0.01 0.02 
2012 0.00 0.00 0.00 1.00 1.00 1.00 0.20 0.17 0.22 0.23 0.27 0.28 0.02 0.01 0.02 
2013 0.00 0.00 0.00 1.00 1.00 1.00 0.23 0.17 0.23 0.24 0.27 0.28 0.02 0.01 0.02 





 Table 9 displays the results of a Welch two-sample t-test, comparing each of the yearly 
HEDIS® scores of the pre-PSM created comparison group (PC) and the post-PSM created 
comparison group (PSMC). Comparing the Intervention group to the Pre-PSM comparison 
group, there is a statistically significant difference in mean group HEDIS® score at the 0.05 
significance level for the years 2010, 2011, 2013, and 2014. However, after PSM, there is no 
statistically significant difference in HEDIS® scores at the same significance level for any year. 
Table 9: HEDIS® Immunization Status Score by Year, Comparing the Intervention Group 
to Comparison Groups, Welch Two-Sample T-Test 
 
Calendar Year 
Group Mean, HEDIS® Immunization  
Status Score (%) 
CI 
(p-value) 
I PC PSMC I vs. PC I vs. PSMC 
2010 0.17 0.12 0.15 
-0.09 – -0.01 
(0.02) 
-0.07 – 0.04 
(0.63) 
2011 0.21 0.14 0.19 
-0.11 – -0.02 
(<0.01) 
-0.08 – 0.05 
(0.63) 
2012 0.20 0.17 0.23 
-0.03 – 0.01 
(0.12) 
-0.03 – 0.09 
(0.35) 
2013 0.23 0.17 0.23 
-0.11 – -0.02 
(<0.01) 
-0.06 – 0.06 
(0.93) 
2014 0.24 0.18 0.22 
-0.10 – -0.03 
(<0.01) 




SPECIFYING STATISTICAL APPROACH  
 
The relationship between the data used for this analysis is complex, not only in it is 
collection (see Figure 7), but also due to its hierarchical structure. Figure 11 is a simplified 
visualization of the data’s hierarchical nature. As Figure 11 shows, two providers (Level 2) may 





practice, these relationships may be even more complex: over time, providers may move 
between primary groups10, and thus have different group members. 
 
 
Figure 11: Depiction of Three-Level Design 
 
There is also varying levels of uncertainty across each level of the data, with each level 
allowing for the integration of background information to inform the likelihood. For example, 
provider-level immunization rates are likely different than group-level immunization rates.  
To address the many relationships between and the hierarchical nature of the data, I used 
a Bayesian-modeling method to address those relationships directly. This choice helps to address 
four concerns with modeling these data using a frequentist approach: (1) complexity of the 
relationships between the data; (2) the resulting uncertainty at each level of the data; (3) the 
relatively low sample size; and (4) the greater generalizability of the posterior distribution. 
According to Schoot and Depaoli, Bayesian statistics offer methodological benefits that address 
all four concerns (van de Schoot & Depaoli, 2014). 
Because of this, a Bayesian approach can introduce prior distributions and current 
likelihood to model these differences. 
                                                 





Furthermore, although this analysis uses many data points, the data is aggregated at the 
provider- and group-level, with the provider being the unit of analysis. This reduction process 
reduces the sample size to 294, a relatively small sample. 
Finally, the Bayesian approach to evaluating posterior distributions allows me to report 
the probability that a mean estimate resides within an upper and lower bound (credible interval) 
for the sample population studied (van de Schoot & Depaoli, 2014).  
 
TESTING MODEL SPECIFICATION 
 
According to Sung et al. and van de Schoot and Depaoli, research using Bayesian 
statistics should present the following information: (1) the statistical program and sampling 
method, (2) the statistical model, (3) a discussion of prior distributions, and (4) any sensitivity 
analysis conducted, including a goodness-of-fit test (Johnson, 2004; Sung et al., 2005; van de 
Schoot & Depaoli, 2014).  
Glickman and van Dyk (2007) break Bayesian analysis into four steps:  
1. Formulate probability model that fits the data; 
2. Determine prior distributions, which quantify uncertainty for unknown model 
parameters before the data are observed; 
3. Using the data, determine the likelihood function. The likelihood function is 
combined with the prior distributions to determine the posterior distribution. 
Determining the posterior distribution quantifies uncertainty after the data is 
observed; and 
4. Summarize features of the posterior distribution or calculate quantities of interest 





 Before evaluating a model’s outcomes, Bayesian analysis relies on software and 
parameters to specify the simulation. Each execution used in this analysis may have different 
parameters, such as iterations (or the number of times the model is run to generate posterior 
samples), thinning (the number of samples dropped per iteration), burn-in (the number of initial 
samples dropped to account for initial mixing of values), chains (the number of separate initial 
values that start an iteration), and adaptation (the initial values used before sampling that 
maximizes efficiency).  When calling out or comparing models, I provide these parameters. 
Upon arriving at step four of the Bayesian analysis process, I evaluated each model 
against each other model.  The model evaluation process relied on two goodness-of-fit tests, a 
modified 2-like statistic and the Deviance Information Criterion (DIC). The modified 2-like 
goodness-of-fit test compares the proportion of posterior means exceeding the 95th quantile of a 
2 distribution based on equally probable quantiles of a Poisson distribution derived at the base 
model’s mean (Johnson, 2004). The DIC is a statistic used to compare models for their estimated 
expected discrepancy in predicting the same outcome with different data (Gelman, Andrew, 
Carlin, John B, Stern, Hal S., Rubin, 2004). 
 
Formulation of Probability Model 
To determine the appropriate statistical model, I considered the structure of the dependent 
variable. Because the primary objective of this analysis is to determine whether there is any 
difference in a provider’s quality score, comparing providers who achieved meaningful use using 
a certified EHR and those who did not have an EHR, and because the model is hierarchical and 





assumes that individual providers who may be a part of the same group using the same EHR will 
have his or her own approach to using the system and interacting with patients. 
I now turn to details of the hierarchical model, the first step being the probabilistic 
distribution for the dependent variable. The dependent variable in this analysis is count data – the 
number of successful administrations of all required dosages of a vaccine under Immunization 
Status Score, Combination 7 for all patients attributed to a PCP within a calendar year. A major 
consideration for modeling count data is its dispersion (spread). For data that is over-dispersed, 
meaning the variance is greater than the mean, the negative binomial, instead of the more 
common Poisson distribution, is more frequently used (Ntzoufras, 2009). 
As shown in Table 10, listing the variance versus mean for each measurement year shows 
variances many times the means, provided support for modeling these data using the negative 
binomial distribution. Additionally, an over-dispersion test using the change-point approach used 
in this analysis – summing the successes for years 2013 and 2014 – results in the same 
conclusion. 
 
Table 10: Count of Successful Vaccine Administrations, 
Variance Versus Mean, by Year 
 
Calendar Year 
Vaccine Administration Counts  
Group Variance Group Mean Variance/Mean 
2010 93.27 4.34 21.49 
2011 87.62 4.91 17.85 
2012 141.67 6.32 22.42 
2013 154.69 6.28 24.63 






Vaccine Administration Counts  
Group Variance Group Mean Variance/Mean 
2013+2014 471.67 12.01 39.27 
 
 
Although the negative binomial model may be more frequently used for over-dispersed 
data, other factors may be considered when choosing the appropriate model, particularly the 
distribution of posterior kernel density plots and how well the model predicts the count of 
successes compared to the number of actual successes. A posterior kernel density plot is a 
smoothed histogram displaying the estimates of the marginal conditional probably of sample 
results following an MCMC simulation (Alexander, Allen, & Bindoff, 2013; Ho et al., 2007). 
The iterative tuning process for formulating the model is specified in step three, determining the 
likelihood function.  
I specified multiple models in an iterative fashion by first specifying the hypothesized 
model as a baseline, and then iteratively modifying the base model, using the DIC as the measure 
of merit. The hypothesized base model is a hierarchical, random effects, negative binomial 
model.  I tested the impact of various groupings of covariates on the DIC. Then, taking the top 
four covariate combinations that produced the lowest DIC, I then modeled a Poisson versus 
negative binomial model, a non-hierarchical version of the model, a fixed- versus random-effects 
version, and the inclusion of a propensity score covariate11 (see Appendix 3).   
                                                 
11 Research on the necessity of adding to an analytic model the propensity score as a latent variable (“covariate 
adjustment”) is mixed. McCandless, Gustafson, and Austin (2008) argue that researchers using propensity score 
analysis may model the uncertainty around a propensity score using Bayesian analysis (McCandless, Gustafson, & 
Austin, 2009). This approach would allow for propensity score covariate adjustment, or the inclusion the propensity 
score in the analytic model. Garrido (2016) discourages propensity score covariate adjustment, as it does not allow 
for balancing covariates, leads to inefficient estimates, among other things (Garrido, 2016). Because including the 
propensity score either improved or had no impact on the DIC across all model specifications, I included the 
propensity score as a latent variable. 





Deciding on Prior Distribution 
Prior distributions used throughout the model specification process are all non-
informative conjugate priors. A non-informative conjugate prior is a higher-level prior 
distribution that is within the same family as the underlying distribution it is feeding within the 
model, but its distribution is specified to be vague (Glickman & Dyk, 2007).  
 
Likelihood to Posterior Distribution 
 The likelihood function is derived by the equation (2), which states that the likelihood of 
theta, given y is the product of each of the probabilities of y given theta: 
 





The posterior distribution of 𝑝(𝜃|𝑦) is derived from Bayes’ theorem or Bayes’ rule, 
where the posterior distribution of theta given y is proportional to prior distribution of theta 
times the likelihood of theta given y (Glickman & Dyk, 2007).  (equation 3):  
 






 ∝ 𝑝(𝜃)𝐿(𝜃|𝑦) 
 
 The calculation of the posterior distribution may be achieved through software. All 
models evaluated for this analysis are run using R (R Core Team, 2017). The package rjags 
(http://mcmc-jags.sourceforge.net) allows the user to build Bayesian analysis Using Gibbs 





2016). Gibbs sampling is a flavor of MCMC simulation that facilitates the “full conditional 
distributions of each unknown stochastic node conditional on the values of all other nodes” 
(Lunn, David, Spiegelhalter, David, Thomas, Andrew, Best, 2009). Its power is that it allows the 
analyst to articulate the desired model, without worrying about the behavior of test statistics 
associated with that model. To obtain desired outputs and to run diagnostics on MCMC samples, 
I used the Convergence Diagnosis and Output Analysis (CODA) package (Plummer, Martyn, 
Best, Nicky, Cowles, Kate, Vines, 2006).  
 
Evaluating Posterior Results 
To evaluate the various models, I visually inspected the sampling distributions for key 
nodes of the model to determine whether the samples are converging around a mean.  For 
Bayesian models run using the CODA package, researchers can view posterior trace plots, which 
visualize the mean estimate for the node for each iteration and each chain. A chain is a posterior 
sample that begins from a different starting point than another chain. Researchers can also view 
kernel density plots, a smoothed histogram displaying the estimates of the marginal conditional 
probably of sample results following an MCMC simulation (Alexander et al., 2013; Ho et al., 
2007). As shown in Figure 12, the key nodes observed include: the number of success expected 
(r.expected), the number of successes observed from the data (r.observed); and by provider and 
by EHR user (p.provider), the proportion of all patients affiliated to the provider who meet 
Immunization Status Score, Combination 7; and the primary outcome of interest, the change in 
Immunization Status Score due to EHR use (delta.delta.mean.EHR). 
Next, I ran diagnostics on the quality of mixing and the presence of autocorrelation. 





MCMC samples, autocorrelation can occur either within a sampling chain or between sampling 
chains. The Gelman and Rubin diagnostic statistic measures convergence in iterations and across 
chains by comparing within- and between-chain variances, with values close to 1 signaling good 
convergence (Martyn et al., 2016). I monitored autocorrelation, first using the Raftery and Lewis 
diagnostic and then generating autocorrelation diagrams. The Raftery and Lewis diagnostic 
calculates an “Independence Factor” for each variable within a chain. Values greater than 5 
indicate autocorrelation (Martyn et al., 2016). No posterior estimates possessed an Independence 
Factor greater than 3. 
Following the evaluative process outlined above, I identified two best-fit models, each 
are hierarchical, random effects models, with a Poisson distribution, and a propensity score 
covariate. One way to visualize a Bayesian model is to use a Directed Acyclic Graph (DAG). A 
DAG displays quantities represented by nodes, with each node linked to other nodes via arrows 
showing direct dependence (Lunn, David, Spiegelhalter, David, Thomas, Andrew, Best, 2009). 
Figure 12 is a DAG displaying a hierarchical logit model (comparing the HEDIS® score of EHR 
users to non-users) with a Poisson distribution at the provider (j,k) level. The key parameter is 
delta.delta.mean.EHR, the change in, the change in immunization status score due to EHR use. 
The model incorporates fixed covariates for demographics, random effects at the provider (j) 
level, and data-derived group-mean data12. Prior distributions are all non-informative priors. 
                                                 
12 Modeling fixed effects at the group level using the by-year, by-provider, group mean immunization status score 






Figure 12: Directed Acyclic Graph for a Hierarchical Poisson Distribution for  
HEDIS® Scores, without Propensity Score Covariate Adjustment 
Single ovals indicate stochastic nodes (variables with randomness and probability distributions), 
double ovals indicate deterministic nodes (variables dependent on parents), rectangles are 
deterministic nodes from the data. See Table 11 for explanations of the variable names. 
 
In Figure 12, the hierarchical version of the logit model is specified at p.provider[j,k]. 
The logit model (with Poisson distribution) is fed by a series of data-derived constants (non-
distributional covariates), stochastic nodes, and deterministic nodes. Stochastic nodes are 
variables with randomness and probability distributions. Deterministic nodes are variables 








Table 11: List and Description of Nodes 
Node Description Notes 
Data-Derived Deterministic Nodes 
p.preexp[j] The probability of successfully meeting 
Immunization Status Score Combo 7 pre-
intervention (pooled years 2010 and 2011) 
 
covariates[j] State Regulated Payor EHR Incentive Program 
participation, each of 2011-2013 and 2014 and 
licensure survey data for prior EHR use in 
years 2009 and 2010* 
 
2013GrpProp[k] The total group Immunization Status Score 
Combo 7 group rate by group for 2013 
 
2014GrpProp[k] The total group Immunization Status Score 
Combo 7 group rate by group for 2014 
 
n.provider[j] The number of providers in the analysis (294)  
indicator.EHR[j] A binary variable indicating whether provider 
is in the intervention group 
 
PSM[j] Provider-specific propensity score  
Stochastic Nodes 
delta.noEHR[j] The change in the probability of successfully 
meeting Immunization Status Score for non-
EHR users 
 





delta.noEHR.prec Variance of population mean change in 




delta.delta.EHR[j] The change in the probability of successfully 
meeting Immunization Status Score, 
comparing EHR users to non-EHR users. 
 
delta.delta.mean.EHR Population mean change in Immunization 




delta.EHR.prec Variance of population mean change in 




r.observed[j] The observed number of successes 
(Immunization Status Score numerators) 
Inferred by 
p.provider, but fed 
directly from 






Node Description Notes 
Error[j] Provider-level random-effects  
mean.error Population-level random effects Non-informative 
normal conjugate 
prior 




Delta1[j]§ The primary node estimating the change in the 
probability of successfully meeting 





p.provider[j,k] The success rate for provider [j] in group [k].  







As stated above, sensitivity analysis during model specification centered around the 
model primary distribution (negative binomial versus Poisson), addition of covariates, and the 
number of iterations.  I chose the primary model parameters based on posterior trace, kernel 
density plots, and DIC, with more evidence supporting a Poisson distribution than negative 
binomial. The DIC is a statistic used to compare models for their estimated expected discrepancy 
in predicting the same outcome with different data (Gelman, Andrew, Carlin, John B, Stern, Hal 
S., Rubin, 2004).  
Following the above process, I narrowed the models to four Poisson distribution models, 
both executed with 1,000 adaptations, 20,000 iterations, 4 chains, 1,000 burn-in. This means that 
* As stated in the Study Design section, the author removed calendar year 2012 from the analysis to account for 
various unknown time periods in which EHR Incentive Program participants may have installed their EHRs. See 
Figure 4. 






final posterior distributions are evaluated at 20,000 samples in each of 4 chains (adaptions and 
burn-in are accounted for before initializing iterations).  
To compare models, I used a modified 2-like goodness-of-fit test (A. Gelman et al., 
1996; Johnson, 2004). A tradition 2-statistic compares the sum of squares of standardized 
residuals for the expected values under a particular model (Gelman et al., 1996). A weakness in 
Gelman’s approach to developing a 2-like statistic is that it does not have a 2 distribution. 
Having a 2 distribution facilitates model comparison through p-values (Johnson, 2004). One 
component of Johnson’s 2-like goodness-of-fit test compares the proportion of posterior means 
exceeding the 95th quantile of a χ9
2 distribution based on equally probable quantiles of a Poisson 
distribution derived at the base model’s mean.13  
Table 12 compares the top two Poisson models goodness-of-fit as evaluated by the 
posterior mean samples of the expected number of successful Immunization Status Combination 
7 Scores and the DIC. Column 3 of Table 12 shows that the posterior distribution for the odds of 
successfully meeting Immunization Status scores is slightly better for the model containing both 
State Regulated Payor Incentive Program and EPSDT participation. However, the model 
containing only State Regulated Payor Incentive Program participation generates a lower DIC. 
Due to the strength of the chi-square-like statistic’s ability to detect nonconformance of the 
evaluated model against a base model using the modeled data’s mean, I chose to report results 
using Model 2, below. 
 
 
                                                 
13 According to Johnson, bin quantiles used for the K-1 2 degrees of freedom calculations may be calculated as the 





Table 12: Goodness-of-Fit Comparison Statistics 
Model Covariates 








State EHR Incentive Program 






Note 1: Column 3 compares the proportion of mean samples exceeding the 2 distribution with 9 degrees of freedom at 0.05 
significance level.  













This study investigates the effect of adopting an EHR and meeting the Meaningful Use 
criteria Clinical Quality Measure (eCQM) NQF 0038 “Childhood Immunization Status”, on 
HEDIS®-based quality metric, Childhood Immunization Status (CIS) Combination 7, comparing 
EHR users to non-users pre-and post-implementation of the EHR Incentive Program in Maryland 
Medicaid. To estimate this effect, I modeled a Poisson distribution, creating the node Delta1[j]. 
The covariate delta.delta.EHR[j] estimates the change in the log-odds of meeting CIS for each 
provider, comparing EHR users to non-users. This formula is shown in Equation (4). 
 
(4)            𝐷𝑒𝑙𝑡𝑎1[𝑗] = 𝑑𝑒𝑙𝑡𝑎. 𝑑𝑒𝑙𝑡𝑎. 𝐸𝐻𝑅[𝑗] ∗ 𝐸𝐻𝑅. 𝑖𝑛𝑑𝑖𝑐𝑎𝑡𝑜𝑟 + 𝑑𝑒𝑙𝑡𝑎. 𝑛𝑜𝐸𝐻𝑅[𝑗] + 𝑃𝑆𝑀[𝑗] 
 
 
Bayesian analysis allows me to calculate the mean change in the change in CIS due to 
EHR use, as specified in delta.delta.mean.EHR (see the stochastic, population-level node feeding 
delta.delta.EHR[j] in Figure 12). delta.delta.mean.EHR is used to calculate the posterior 
population estimated mean for the log-odds change in CIS due to EHR use.  Figure 13 shows the 
posterior sampling distribution for the mean change in the log-odds change in CIS due to EHR 
use. Each color of the trace plot represents a chain in the simulation that begins at a unique initial 





centering around a mean of 0.20 (log-odds of 0.20). The kernel density plot – or smoothed 
frequency graph – shows the same mean, 0.20.  
 
Figure 13. Trace and Kernel Density Plot of the Log-Odds of the Mean Change in the 
Change in CIS Due to EHR Use 
 
By exponentiating the mean posterior value of 0.20 estimated and displayed in Figure 13, 
I can report results as the estimated improvement in the odds of improving CIS due to EHR use.  
Table 13 shows the mean and credible interval for the exponentiated estimates from Figure 13.  
 
Table 13. Mean Change in the Change in Odds of Increasing CIS Score Due to EHR Use 
Variable Mean SD 
95% 
Credible Set 
delta.delta.mean.EHR 1.21 4.50 (0.88 – 1.73) 
 
 
Given prior information for and probabilities obtained from the data used in this study, I 
estimate that for providers using EHR’s in this study, their use of the EHR increased the odds of 
meeting immunization status score requirements for providers by an average of 21 percent. 





However, if the credible set of the odds contains 1, then EHR use may not increase the odds of 
meeting CIS score criteria for providers. Because the 95 percent credible set does contain 1, the 
percent improvement in odds is not significant. 
Thus, based on prior information and the probabilities calculated with this data set, for 
Maryland Medicaid MCO network providers, in the two-year, post-EHR implementation period 
(the “intervention”), there is no statistically significant difference in the percent change in CIS 
Combination 7 score, comparing providers meeting Meaningful Use with Clinical Quality 
Measure (eCQM) National Quality Forum 0038 “Childhood Immunization Status,” to non-EHR 
users. 
A secondary aim of this study is to better understand whether the change in provider 
quality score differs by EHR developer. This question may be particularly important to answer 
given the large standard deviation shown in the estimated increase in the mean odds of meeting 
CIS criteria.  
To evaluate the correlation between a particular EHR developer and a provider’s 
probability of successfully meeting Childhood Immunization Status (CIS) Combination 7, I re-
specified the model at Figure 12 to break the overall EHR-use delta into seven interaction terms, 
one for each of the six EHR developers with at least 10 users, and a seventh interaction term for 
all other EHR users. As is detailed above, each vendor-specific delta.delta interaction term is fed 
by a population-based mean. This re-specification results in equation (5). Equation (5) allows me 
to estimate the mean change in the change in the odds of meeting EHR immunization status 






(5)             𝐷𝑒𝑙𝑡𝑎1[𝑗]
= 𝑑𝑒𝑙𝑡𝑎. 𝑑𝑒𝑙𝑡𝑎. 𝐸𝐻𝑅𝑣𝑒𝑛𝑑𝑜𝑟1[𝑗] ∗ 𝐸𝐻𝑅. 𝑖𝑛𝑑𝑖𝑐𝑎𝑡𝑜𝑟 ∗ 𝐸𝐻𝑅𝑣𝑒𝑛𝑑𝑜𝑟1[𝑗]
+ 𝑑𝑒𝑙𝑡𝑎. 𝑑𝑒𝑙𝑡𝑎. 𝐸𝐻𝑅𝑣𝑒𝑛𝑑𝑜𝑟2[𝑗] ∗ 𝐸𝐻𝑅. 𝑖𝑛𝑑𝑖𝑐𝑎𝑡𝑜𝑟 ∗ 𝐸𝐻𝑅𝑣𝑒𝑛𝑑𝑜𝑟2[𝑗] …
+ 𝑑𝑒𝑙𝑡𝑎. 𝑛𝑜𝐸𝐻𝑅[𝑗] + 𝑃𝑆𝑀[𝑗] 
 
 
To estimate whether the change in the odds is statistically significantly different than the 
overall EHR-use posterior estimate from Table 13, I performed a Welch two-sample t-test for 
unequal variances, comparing each EHR-developer specific posterior population mean estimate 
to the overall intervention estimated mean change in probability of meeting CIS Combination 7. 
Table 14 lists only those EHR developers with ten or more users and the group mean 
change in HEDIS® scores. Only those estimates with credible sets not containing 1 are denoted 
with an asterisk.  Only Epic produced a credible set that did not contain 1, when comparing the 
group mean change in immunization score to that of the overall intervention group mean.  




Absolute Difference in Odds of Meeting 
CIS, Comparing EHR Developer to All 
EHR Users 











Note: The ellipses denote continue iteration of the equation interact terms, each for EHR vendors 








Absolute Difference in Odds of Meeting 
CIS, Comparing EHR Developer to All 
EHR Users 
GE Healthcare 17 0.59 






 In sum, comparing EHR users meeting Meaningful Use and successfully meeting Clinical 
Quality Measure (eCQM) National Quality Forum 0038 “Childhood Immunization Status” in 
Calendar Year 2013 (the “treatment” group) to a propensity-score matched provider population 
not adopting an EHR (the “comparison” group) two-years each during pre- and post-
implementation, revealed no statistically significant difference in the odds of meeting Childhood 
Immunization Status (CIS) Combination 7.  Further, only one EHR developer’s product showed 
a statistically significant negative difference in the probability of meeting Childhood 
Immunization Status (CIS) Combination 7, compared to the overall group intervention mean.
Note 1: Welch, two-sample t-test, comparing EHR developer user change in group mean odds 
to EHR developer overall change in mean odds (1.21). 
Note 2: EHR vendors with group membership less than 10: Acrendo Software, Inc., Amazing 
Charts, athenahealth, Inc., Bizmatics, Inc., Connexin Software, Inc., drchrono, Inc, Enable 
healthcare, Inc., Glenwood Systems, LLC., Greenway Health, LLC, MedPlus, Practice Fusion, 
and Viteria Healthcare Solutions, LLC. 














This study contributes to the small but growing literature on the effects of EHR use on 
health care quality by focusing specifically on the Medicaid managed care population. I 
constructed a quality outcome measure by applying a version of the HEDIS® specifications for 
Childhood Immunization Status (CIS), Combination Measure 7 to the individual provider and 
not Managed Care Organization (MCO) level, as is traditionally done.  To apply the CIS 
Combination 7 measure to the provider level, I queried the Medicaid health care encounter file to 
identify the earliest Evaluation and Management (E&M), preventative medicine CPT code, to act 
as a binding agent between a patient and a provider. Once I identified the group of patients for 
whom the provider would be responsible for, I totaled the number of patients receiving the 
specified type and number of immunizations.  
Using a Bayesian hierarchical model, I found no statistically significant difference in the 
change in the odds of meeting Childhood Immunization Status (CIS) Combination 7, comparing 
certain EHR users to a propensity-score matched group of EHR non-users. Additionally, among 
those providers who did adopt an EHR, comparing provider group means by EHR developer to 
the overall EHR user group mean, only one EHR developer product produced a statistically 





Combination 7. However, this change in odds is a decrease in the odds of meeting CIS 
Combination 7, compared to the overall difference in odds of meeting CIS due to EHR use.  
 
DISCUSSION AND POLICY IMPLICATIONS 
  
 Nearly seven years after the start of the Medicaid EHR Incentive Program, researchers, 
providers, and policymakers have voiced their opinions about how the EHR Incentive Program 
has impacted providers and patients. For researchers, the creation of EHR certification has 
created more standardized EHR products, which has helped researchers to isolate EHR 
functionality. But, this rigidity in EHR product functionality for certification creates barriers to 
use among certain health care provider populations and settings, particularly solo practitioners, 
specialists, and rural providers (Heisey-Grove, Danehy, Consolazio, Lynch, & Mostashari, 
2014). As a response to these concerns, as well as a response to the uncertainty around the link 
between Meaningful Use measures and improved care, the Centers for Medicare and Medicaid 
Services (CMS) is exploring how to change “Meaningful Use” to “Meaningful Measures” (CMS, 
2018).  
 Despite the change in policy focus from mandating certain functions and reporting to 
more outcomes-based measures and value-based payments, the digitization of the health record 
remains and will likely play a large role in the future of health care. All major national policies 
around value-based, instead of fee-for-service-based, payments either include requirements that 
health care providers use CEHRT or are incentivized to do so.14 This means that over time, as 
more providers adopt CEHRT, the level, fidelity, and timeliness of clinical data’s availability to 
                                                 
14 See the requirements for participation for the Quality Payment Program (QPP) at 






the three major stakeholders in the health system (see Figure 1) will only improve. For Medicaid 
agencies particularly, as they continue to leverage federal funding to modernize their Medicaid 
Management Information Systems (MMIS), Medicaid agencies will be integrating clinical data 
with administrative data to measure quality. In this future state, Medicaid agencies will likely use 
quality scores as calls-to-action, revealing trends in patient health status to providers and 
Managed Care Organizations as a means to target interventions to improve quality for the 
individual before health declines, instead of using quality scores as a posterior, population-based 
summary statistic. 
However, for immunization status reporting particularly, it does not appear as though 
EHR use has a differential impact on immunization rates. This study design does not provide 
information on particular EHR implementation approaches or whether EHR use improves 
immunization status (as measured by over- or under-immunization rates), thus I cannot conclude 
whether policies that continue to incent or require EHR use are beneficial for immunization 
status rates.  Since many providers have already adopted EHRs, providers should begin to fully 
utilize their EHRs by imbedding them into their work flow and leveraging functionality to drive 
clinical performance. This research highlights that, although providers may choose to be 
measured on a particular quality metric due to their specialization and patient population, just 
because they have adopted an EHR does not mean that that EHR will improve their score or that 
the EHR is meant to improve that particular measure’s score. 
Further, due to the relatively short post-implementation timeline, I can neither confirm 
nor deny the presence of a “ramp-up” period for fully utilizing an EHR, as hypothesized by 
Cheriff, Kapur, Qui, and Cole (2010). There is some level of evidence to support the theory that, 





immunization rates, the initial two-years of using an EHR may decrease the odds of meeting 
immunization status scores. Why this may be the case and how far-reaching the impact is cannot 
be concluded using this study. 
Because there is some evidence to support the theory that the impact of EHR use on 
immunization status score vary by EHR developer, the developer that a provider chooses should 
play a key role in the provider’s ability to deliver quality care. Unfortunately, just at a time when 
CEHRT has made it easier for providers to select technology with certain baseline functionality, 
it has also made it difficult for providers to obtain EHRs that are tailored to their needs, which is 
where EHR use will actually be more meaningful (Payne et al., 2015). And, because of the high 
transition costs to move to another EHR platform, providers may be less likely to switch to a 
more tailored EHR (ONC, 2105).  By reducing information blocking by vendors and other 
provider group and reducing the regulatory requirements for CEHRT, providers may be more 
likely to obtain either new EHRs or software that is a compatible add-on to their current EHR 
systems that can help them optimize quality scores and eventually patient outcomes. 
 
STRENGTHS AND LIMITATIONS 
 
Some of the major strengths of this study are found in the design and in the selection of 
outcome measures. This research uses an interrupted time series design that retrospectively 
follows particular providers and comparators over time. The use of a Bayesian hierarchical 
model accounts for correlation between providers and their practices. The study design creates a 
“contamination buffer” which allows for various implementation timelines for providers 





scores), and uses a retrospective approach to obtain data that has already been collected. The data 
collection is routine and is generally calculated using claims data supplied by MCOs.  
Reporting results using Bayesian analysis is in contrast to the frequentist approach, which 
can only report confidence intervals in relation to replications of the exact same experiment (van 
de Schoot & Depaoli, 2014). The former approach is preferable in this analysis, as I would like 
to present results as impacting the population and not simply the population within the same 
experiment. Additionally, Bayesian analysis allows me to model uncertainty, which may arise 
around unmeasured motivational confounders, such as other programs that overtly or covertly 
incentivized EHR use. 
The analytic model uses propensity score matching to create the comparison groups and a 
Medicare-approved patient attribution method to link patients and providers. The high match rate 
score for the comparison population reduces the likelihood of selection and unmeasured 
confounding bias, providing confidence in the estimated treatment effect (EHR use) on the 
outcome of interest (odds of meeting immunization status requirements). Additionally, the 
Medicare-approved patient attribution method provides support that provider-based 
immunization status rates are a good measures of a provider’s patient cohort’s immunization 
status.  
Due in part to the nested nature of the study, the introduction of each layer adds more 
“noise” to the model. To mitigate the noise, this research could have analyzed HEDIS® scores at 
the practice level; however, such an analysis would not address the impact of EHR use on a 
provider’s ability to improve health care quality, which is the primary research question. The 





distributions (via random effects), thus mitigating the impact of uncertainty at each level while 
allowing me to answer the primary research question.  
As with all studies that utilize PSM to develop comparison groups, this study assumes 
non-ignorability or selection on observables to define covariates for propensity score matching. I 
tried to mitigate this weakness by using data supported by immunization research. 
A weakness of this study is that I only had two years of data post implementation. This 
study compares data two years before and two years after implementation of the Medicaid EHR 
Incentive Program and expects to see a noticeable change in quality after EHR implementation 
within one year. Although it is reasonable to assume that a change in HEDIS® scores may occur 
within a year, it may not be accurate to assume that every provider who self-selected as 
implementing an EHR in 2013 did so at the same time and at the same level.  It is possible that 
EHR implementation may take different providers different amounts of time and that, once 
implemented, different providers may take longer to fully integrate the system into their practice 
workflow.  However, it would be difficult to know when exactly a provider fully implemented an 
EHR system; and, to make controls comparable, it would be difficult to obtain comparable 
quality measures at set intervals for every provider. 
An additional weakness in this study is the assumption that a provider’s primary group is 
the group from which a majority of their claims and encounters derive or, if this number remains 
equal across all groups, the amount of time spent with a group over the lifetime of the provider’s 
enrollment with Medicaid. This assumption is plausible, as claim volume attributed to and time 
spent with a group likely stand for a proxy for the amount of physical time spent delivering care 





Another limitation of this study is the assumption that Medicaid recipients are similar 
across the providers that see them. Some studies attempt to mitigate this risk by adding a case-
mix variable that accounts for the disease severity of the individual recipient. In this study, I 
assume that the independent variable of interest (meeting Meaningful Use) is independent of the 
disease severity of a provider’s patient population and the provider’s decision to acquire an EHR. 
Lastly, I did not control for particular group and provider characteristics such as how a 
group implemented their EHR, how an individual provider used the EHR, and whether or not 
providers are aware of the immunization schedule and will administer vaccines according to the 
schedule. “Implementation” includes training as well as the activation of non-CEHRT-required 
functionality, such as alerts, which may differentially impact how a provider delivers care.  




 Additional areas of research resulting from this study include: (1) the investigation of 
individual EHRs that showed a statistically significant difference in the probability of meeting 
Childhood Immunization Status (CIS) Combination 7 to determine whether they provided 
additional functionality that impacted immunization rates; (2) quantifying the extent to which 
using an EHR impacted the over- or under-immunization of children empaneled to their Primary 
Care Provider; and (3) using the clinical information contained within an EHR to calculate the 
same  CIS score and comparing it to claims and encounter data to determine whether EHRs more 


















List of variables and their description 
PSPEC_Cat: Health care provider specialty. 
PV_10_Tot: Health care provider total claims and encounters for CY 2010. 
PV_10_Less2_Prt: Health care provider percent of total claims and encounters for children <=2 on date of service, CY 
2010. 
PV_10_3_18_Prt: Health care provider percent of total claims and encounters for children <=18 and >=3 on date of 
service, CY 2010. 
PV_11_Tot: Health care provider total claims and encounters for CY 2011. 
PV_11_Less2_Prt: Health care provider percent of total claims and encounters for children <=2 on date of service, CY 
2011. 
PV_11_3_18_Prt Health care provider percent of total claims and encounters for children <=18 and >=3 on date of 
service, CY 2011. 
PV_12_Tot: Health care provider total claims and encounters for CY 2012. 
PV_12_Less2_Prt: Health care provider percent of total claims and encounters for children <=2 on date of service, CY 
2012. 
PV_12_3_18_Prt Health care provider percent of total claims and encounters for children <=18 and >=3 on date of 
service, CY 2012. 
VFC_Part: Dichotomous variable for ever-participation in the Vaccines for Children Program.  
X10_PROV_GRP_NMB_rcd: Predominate group affiliation, CY2010. 
X11_PRV_GRP_NMB_rcd: Predominate group affiliation, CY2011. 
X12_PRV_GRP_NMB_rcd: Predominate group affiliation, CY2012. 
X2010_EPSDT: Participation in the Early Periodic Screening and Diagnosis Program, CY 2010. 
X2011_EPSDT: Participation in the Early Periodic Screening and Diagnosis Program, CY 2011. 









Propensity Score Matching Balance Table for  















At a 0.1 mean difference threshold, PV_10_Less2_Prt, PV_11_Less2_Prt, and PV_11_3_18_Prt, exceeded 






















1 1120 1122 1120 1120 1120 1610 1119 
2 1123 1125 1123 1123 1123 1674 1123 
3 1125 1126 1125 1126 1125 1768 1125 
















Note 1: For each model number, the covariate package changes. Each covariate package is applied to a different 
model parameter in sequence, first by level, then specification, then distribution. The best version of the “level” 
model, is then tested against each type of “specification.” The best “level” and “specification” pair is tested against 
each “distribution.” Last, the propensity score is added as a covariate. 
 
Note 2:  
Model No. 1 covariates = State EHR Incentive Program Participation 
Model No. 2 covariates = State EHR Incentive Program Participation and EPSDT Participation 
Model No. 3 covariates = EPSDT Participation 
Model No. 4 covariates = State EHR Incentive Program Participation and Past EHR Use (State licensure survey) 
 
*DIC is the penalized DIC; all Poisson models were not penalized.  







Directed Acyclic Graph for a Non-Hierarchical Negative Binomial Distribution for  
HEDIS® Scores, with Fixed Effects. 
 
Single ovals indicate stochastic nodes (variables with randomness and probability distributions), 
double ovals indicate deterministic nodes (variables dependent on parents), rectangles are 
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